Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0005737 cytoplasm	IBA GO_REF:0000033	ACCEPT	Summary: Caspase-9 is predominantly localized in the cytoplasm as an inactive monomer in non-stressed cells [PMID:12782307, deep research]. The IBA annotation from phylogenetic inference is well-supported. Both isoforms would be cytoplasmic as neither has specific targeting signals. Reason: Cytoplasmic localization is well-established for procaspase-9. The deep research confirms "In non-stressed cells, caspase-9 predominantly localizes to the cytosol as an inactive monomer lacking typical mitochondrial targeting sequences." This applies to both isoforms as the CARD domain (retained in both) does not contain targeting signals. Supporting Evidence: PMID:12782307 caspase-9 is in the cytoplasm of non-apoptotic pituitary cells file:human/CASP9/CASP9-deep-research-perplexity.md provider: perplexity
GO:0006915 apoptotic process	IBA GO_REF:0000033	ACCEPT	Summary: Caspase-9 is central to the intrinsic apoptotic pathway. The IBA annotation correctly identifies involvement in apoptosis, which is the canonical function of isoform 1. However, isoform 2 (Caspase-9S) INHIBITS apoptosis as a dominant-negative. Reason: The GO term "apoptotic process" is a broad BP term that applies to proteins involved in apoptosis regardless of whether they promote or inhibit it. The term definition includes regulation. Isoform 1 induces apoptosis while isoform 2 inhibits it - both are involved in the apoptotic process. The IBA inference from phylogenetic conservation is sound for the canonical pro-apoptotic function. Supporting Evidence: PMID:9390557 Activated caspase-9 in turn cleaves and activates caspase-3
GO:0004197 cysteine-type endopeptidase activity	IBA GO_REF:0000033	ACCEPT	Summary: Cysteine-type endopeptidase activity is the core enzymatic function of caspase-9 (isoform 1). CRITICAL: Isoform 2 (Caspase-9S) LACKS this activity as it is missing the catalytic domain (residues 140-289). UniProt explicitly states "Isoform 2: Lacks activity". Reason: This annotation is correct for the canonical isoform 1 (P55211-1). The IBA phylogenetic inference is valid because the catalytic activity is the defining feature of caspase-9 orthologs. The catalytic dyad (Cys-287 and His-237) is conserved across the family. Note that isoform 2 would NOT have this activity. Supporting Evidence: PMID:16916640 Our study demonstrates the efficiency by which the executioner caspases are activated in vivo PMID:9390557 Activated caspase-9 in turn cleaves and activates caspase-3
GO:0005829 cytosol	IBA GO_REF:0000033	ACCEPT	Summary: Cytosolic localization is well-established for procaspase-9 in non-apoptotic cells. The apoptosome forms in the cytosol upon cytochrome c release from mitochondria. Reason: Deep research confirms cytosolic localization: "In non-stressed cells, caspase-9 predominantly localizes to the cytosol as an inactive monomer." Multiple experimental studies confirm this. The IBA annotation is phylogenetically sound. Supporting Evidence: PMID:12782307 caspase-9 is in the cytoplasm of non-apoptotic pituitary cells
GO:0043525 positive regulation of neuron apoptotic process	IBA GO_REF:0000033	ACCEPT	Summary: Caspase-9 plays a documented role in neuronal apoptosis during development and in neurodegenerative conditions. Caspase-9 knockout mice show severe brain abnormalities due to reduced developmental neuronal apoptosis. CRITICAL: This applies to isoform 1 only. Reason: Deep research states: "mice lacking caspase-9 die perinatally with severe brain abnormalities including exencephaly, ventricular obstructions, and protrusion formations." This demonstrates caspase-9's role in neuronal apoptotic processes during CNS development. IBA inference from phylogenetic conservation is appropriate for this well-characterized function of isoform 1. Supporting Evidence: deep-research mice lacking caspase-9 die perinatally with severe brain abnormalities including exencephaly, ventricular obstructions, and protrusion formations
GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage	IBA GO_REF:0000033	ACCEPT	Summary: Caspase-9 is the initiator caspase of the intrinsic apoptotic pathway activated by DNA damage. c-Abl phosphorylates caspase-9 at Tyr-153 in response to DNA damage, promoting apoptosis. CRITICAL: This pro-apoptotic function is isoform 1 specific. Reason: DNA damage triggers the intrinsic pathway through p53-mediated transcription of pro-apoptotic Bcl-2 family members, leading to MOMP, cytochrome c release, and caspase-9 activation. PMID:15657060 demonstrates c-Abl directly phosphorylates caspase-9 in DNA damage response. IBA phylogenetic inference is sound for this core function. Supporting Evidence: PMID:15657060 c-Abl phosphorylates caspase-9 on Tyr-153 in vitro and in cells treated with DNA damaging agents
GO:0004197 cysteine-type endopeptidase activity	IEA GO_REF:0000120	ACCEPT	Summary: IEA annotation of cysteine-type endopeptidase activity is redundant with IBA annotation. Correct for isoform 1, but isoform 2 lacks the catalytic domain. Reason: This is a broader IEA annotation that is consistent with the IBA annotation. While less specific than IBA, it is not incorrect. The catalytic activity is confirmed by multiple experimental studies. Supporting Evidence: PMID:16916640 Caspase-7 is an obligate dimer of catalytic domains, with generation of activity requiring limited proteolysis within a region that separates the large and small chains of each domain
GO:0006508 proteolysis	IEA GO_REF:0000120	ACCEPT	Summary: Proteolysis is a parent term of cysteine-type endopeptidase activity. This is a very general annotation but not incorrect for isoform 1. Reason: Caspase-9 is definitively a protease that cleaves substrates. The term is appropriately general for an IEA annotation. More specific terms are available via IBA and IDA annotations. Supporting Evidence: PMID:9390557 Activated caspase-9 in turn cleaves and activates caspase-3
GO:0006915 apoptotic process	IEA GO_REF:0000120	ACCEPT	Summary: IEA annotation of apoptotic process is redundant with IBA annotation. Correct as caspase-9 is a key player in apoptosis, with isoform 1 promoting and isoform 2 inhibiting the process. Reason: Consistent with other evidence. The IEA provides computational support for the experimentally validated apoptotic function. Supporting Evidence: PMID:9390557 caspase-9 is the most upstream member of the apoptotic protease cascade that is triggered by cytochrome c and dATP
GO:0006974 DNA damage response	IEA GO_REF:0000117	ACCEPT	Summary: Caspase-9 participates in DNA damage response primarily through its role as the executor of DNA damage-induced apoptosis. c-Abl phosphorylates caspase-9 in response to DNA damage. Reason: The deep research and PMID:15657060 confirm caspase-9's role in DNA damage response. The ARBA machine learning annotation correctly captures this function. Supporting Evidence: PMID:15657060 The c-Abl tyrosine kinase is also involved in the apoptotic response to DNA damage
GO:0008233 peptidase activity	IEA GO_REF:0000120	ACCEPT	Summary: Peptidase activity is a parent term of cysteine-type endopeptidase activity. Very general but correct for isoform 1. Reason: This is a very general parent term. More specific annotations are available. Correct for the canonical catalytically active isoform. Supporting Evidence: PMID:16916640 Caspase-7 is an obligate dimer of catalytic domains, with generation of activity requiring limited proteolysis within a region that separates the large and small chains of each domain
GO:0008234 cysteine-type peptidase activity	IEA GO_REF:0000120	ACCEPT	Summary: Cysteine-type peptidase activity is a parent term of the more specific cysteine-type endopeptidase activity annotation. Correct for isoform 1. Reason: Parent term of the more specific annotation. Consistent with caspase-9's function as a cysteine protease using the catalytic dyad of Cys-287 and His-237. Supporting Evidence: PMID:16916640 Caspase-7 is an obligate dimer of catalytic domains, with generation of activity requiring limited proteolysis within a region that separates the large and small chains of each domain
GO:0009411 response to UV	IEA GO_REF:0000117	ACCEPT	Summary: UV irradiation causes DNA damage that can trigger caspase-9-mediated apoptosis via the intrinsic pathway. Reason: PMID:15657060 demonstrates that DNA damaging agents including UV activate caspase-9 through c-Abl-mediated phosphorylation. The annotation captures the role of caspase-9 in UV-induced apoptosis. Supporting Evidence: PMID:15657060 Caspase-9(Y153F) also attenuated DNA damage-induced processing of caspase-9 to p35, activation of caspase-3, and apoptosis
GO:0016787 hydrolase activity	IEA GO_REF:0000043	ACCEPT	Summary: Hydrolase activity is a very general parent term. Caspases hydrolyze peptide bonds. Correct but uninformative for isoform 1. Reason: Very general but correct parent term. The UniProtKB keyword mapping correctly identifies caspase-9 as a hydrolase. More specific terms provide better annotation. Supporting Evidence: PMID:9390557 Activated caspase-9 in turn cleaves and activates caspase-3
GO:0042981 regulation of apoptotic process	IEA GO_REF:0000002	ACCEPT	Summary: Caspase-9 regulates apoptosis. Isoform 1 positively regulates (induces) apoptosis, while isoform 2 negatively regulates (inhibits) apoptosis. This general term encompasses both functions. Reason: This general regulatory term is appropriate as CASP9 is involved in apoptosis regulation through both pro-apoptotic (isoform 1) and anti-apoptotic (isoform 2) mechanisms. The InterPro association correctly identifies this function. Supporting Evidence: deep-research The CASP9 gene generates two functionally antagonistic isoforms through alternative splicing: the pro-apoptotic caspase-9a that retains exons 3, 4, 5, and 6, and the anti-apoptotic caspase-9b
GO:0051604 protein maturation	IEA GO_REF:0000117	ACCEPT	Summary: Caspase-9 (isoform 1) processes/matures other proteins including procaspase-3 and procaspase-7 by proteolytic cleavage. Reason: The annotation captures caspase-9's role in processing downstream effector caspases from their inactive proforms to active enzymes. This is a core function of initiator caspases. Supporting Evidence: PMID:16352606 Apaf-1 oligomerizes to produce approximately 1.4-MDa and approximately 700-kDa apoptosome complexes, and the latter complex directly cleaves/activates procaspase-7
GO:0005515 protein binding	IPI PMID:10206961 An APAF-1.cytochrome c multimeric complex is a functional ap...	MODIFY	Summary: PMID:10206961 demonstrates caspase-9 binding to Apaf-1 in the apoptosome complex. While "protein binding" is too vague, the specific interaction with Apaf-1 is core to caspase-9 function. Reason: "Protein binding" is uninformative. The paper demonstrates CARD-CARD interaction between caspase-9 and Apaf-1 in the apoptosome. A more specific term should be used. Proposed replacements: cysteine-type endopeptidase activity Supporting Evidence: PMID:10206961 Such a complex can be isolated using gel filtration chromatography and is by itself sufficient to recruit and activate procaspase-9
GO:0005515 protein binding	IPI PMID:10376594 Structural basis of procaspase-9 recruitment by the apoptoti...	MODIFY	Summary: PMID:10376594 describes the structural basis of procaspase-9 recruitment by Apaf-1 via CARD-CARD interactions. "Protein binding" is too general. Reason: The specific interaction is CARD domain binding. A more informative term would capture the CARD-CARD interaction that recruits caspase-9 to the apoptosome. Proposed replacements: identical protein binding Supporting Evidence: PMID:10376594 Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1
GO:0005515 protein binding	IPI PMID:11024045 Livin, a novel inhibitor of apoptosis protein family member.	KEEP AS NON CORE	Summary: PMID:11024045 describes Livin (BIRC7), an IAP family member that can bind caspases. Reason: IAP binding is part of caspase regulation but "protein binding" is too vague. The interaction with IAPs is important for regulation but not a core function annotation. Supporting Evidence: PMID:11024045 Livin, a novel inhibitor of apoptosis protein family member
GO:0005515 protein binding	IPI PMID:11084335 ML-IAP, a novel inhibitor of apoptosis that is preferentiall...	KEEP AS NON CORE	Summary: PMID:11084335 describes ML-IAP (BIRC7) interaction with caspases. Reason: IAP interaction is regulatory. "Protein binding" is too vague but the interaction is documented. Supporting Evidence: PMID:11084335 ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
GO:0005515 protein binding	IPI PMID:11230124 Recruitment, activation and retention of caspases-9 and -3 b...	KEEP AS NON CORE	Summary: PMID:11230124 describes recruitment of caspases to Apaf-1 apoptosome and XIAP complexes. Reason: Documents apoptosome assembly and XIAP regulation. "Protein binding" is uninformative but the interactions are relevant. Supporting Evidence: PMID:11230124 Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes
GO:0005515 protein binding	IPI PMID:11242052 A conserved XIAP-interaction motif in caspase-9 and Smac/DIA...	KEEP AS NON CORE	Summary: PMID:11242052 describes the XIAP-interaction motif in caspase-9 and Smac/DIABLO. Reason: IAP binding motif documentation. The caspase-9/XIAP interaction is well-established for regulation of caspase activity. Supporting Evidence: PMID:11242052 A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
GO:0005515 protein binding	IPI PMID:11801603 SMAC negatively regulates the anti-apoptotic activity of mel...	KEEP AS NON CORE	Summary: PMID:11801603 describes SMAC interaction with ML-IAP (BIRC7). Reason: Part of the IAP regulatory network affecting caspase-9 activity. Supporting Evidence: PMID:11801603 SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis
GO:0005515 protein binding	IPI PMID:11821383 CARD-8 protein, a new CARD family member that regulates casp...	KEEP AS NON CORE	Summary: PMID:11821383 describes CARD-8 interaction with caspase-9 via CARD domain. CARD-8 regulates caspase-1 and can interact with caspase-9. Reason: CARD-8 interaction is regulatory. The paper focuses on caspase-1 regulation with caspase-9 interaction being secondary. Supporting Evidence: PMID:11821383 CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis
GO:0005515 protein binding	IPI PMID:12620238 Mechanism of XIAP-mediated inhibition of caspase-9.	KEEP AS NON CORE	Summary: PMID:12620238 provides structural mechanism of XIAP-mediated caspase-9 inhibition. Reason: XIAP binding is a key regulatory mechanism. The structural data confirms the interaction but "protein binding" is too vague. Supporting Evidence: PMID:12620238 Mechanism of XIAP-mediated inhibition of caspase-9
GO:0005515 protein binding	IPI PMID:16189514 Towards a proteome-scale map of the human protein-protein in...	KEEP AS NON CORE	Summary: PMID:16189514 is a large-scale proteome mapping study. Individual interactions may not be validated. Reason: High-throughput study. Interactions should be confirmed by directed studies. Supporting Evidence: PMID:16189514 Towards a proteome-scale map of the human protein-protein interaction network
GO:0005515 protein binding	IPI PMID:16537496 The dependence receptor DCC requires lipid raft localization...	KEEP AS NON CORE	Summary: PMID:16537496 describes DCC dependence receptor signaling involving caspase-9. Reason: DCC receptor signaling is a specific pathway involving caspase-9 activation. Not a core function but a documented regulatory interaction. Supporting Evidence: PMID:16537496 The dependence receptor DCC requires lipid raft localization for cell death signaling
GO:0005515 protein binding	IPI PMID:16936772 Integrin-linked kinase interacts with caspase-9 and -8 in an...	KEEP AS NON CORE	Summary: PMID:16936772 describes integrin-linked kinase (ILK) interaction with caspases. Reason: ILK-caspase interaction is context-specific for adhesion-dependent apoptosis in leukemia cells. Supporting Evidence: PMID:16936772 Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner
GO:0005515 protein binding	IPI PMID:18022362 IAP antagonists induce autoubiquitination of c-IAPs, NF-kapp...	KEEP AS NON CORE	Summary: PMID:18022362 describes IAP antagonists inducing autoubiquitination of c-IAPs. Reason: Part of IAP regulatory network affecting caspase activity. Supporting Evidence: PMID:18022362 IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis
GO:0005515 protein binding	IPI PMID:18723680 Executioner caspase-3 and caspase-7 are functionally distinc...	KEEP AS NON CORE	Summary: PMID:18723680 shows caspase-3 and caspase-7 are functionally distinct, with implications for caspase-9-mediated activation. Reason: Relevant to caspase-9's substrate specificity but "protein binding" is vague. Supporting Evidence: PMID:18723680 Executioner caspase-3 and caspase-7 are functionally distinct proteases
GO:0005515 protein binding	IPI PMID:19153467 The structure of the BIR3 domain of cIAP1 in complex with th...	KEEP AS NON CORE	Summary: PMID:19153467 provides structural data on BIR3 domain of cIAP1 in complex with caspase-9 N-terminal peptide. Reason: Structural data on IAP-caspase interaction. Regulatory rather than core function. Supporting Evidence: PMID:19153467 The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9
GO:0005515 protein binding	IPI PMID:19494828 The Apaf-1*procaspase-9 apoptosome complex functions as a pr...	ACCEPT	Summary: PMID:19494828 describes the apoptosome as a proteolytic-based molecular timer. Reason: This paper provides important mechanistic insight into caspase-9/Apaf-1 interaction dynamics in the apoptosome. The interaction is core to function though "protein binding" is uninformative. Supporting Evidence: PMID:19494828 The Apaf-1*procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer
GO:0005515 protein binding	IPI PMID:19721007 Netrin-1 up-regulation in inflammatory bowel diseases is req...	KEEP AS NON CORE	Summary: PMID:19721007 describes Netrin-1 signaling in colorectal cancer involving dependence receptors. Reason: Netrin-1/dependence receptor signaling is a specific context for caspase activation. Supporting Evidence: PMID:19721007 Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression
GO:0005515 protein binding	IPI PMID:20462491 Structure of an apoptosome-procaspase-9 CARD complex.	ACCEPT	Summary: PMID:20462491 provides structure of apoptosome-procaspase-9 CARD complex. Reason: Key structural study of the core caspase-9/Apaf-1 CARD interaction. Though "protein binding" is vague, the CARD-CARD interaction is essential for function. Supporting Evidence: PMID:20462491 Structure of an apoptosome-procaspase-9 CARD complex
GO:0005515 protein binding	IPI PMID:21827945 The holo-apoptosome: activation of procaspase-9 and interact...	ACCEPT	Summary: PMID:21827945 describes holo-apoptosome structure and procaspase-9 activation and interactions with caspase-3. Reason: Core structural/mechanistic study of the apoptosome. Demonstrates caspase-9 binding to apoptosome and interactions with caspase-3. Supporting Evidence: PMID:21827945 Activation of procaspase-9 on the apoptosome is a pivotal step in the intrinsic cell death pathway
GO:0005515 protein binding	IPI PMID:23516580 The E. coli effector protein NleF is a caspase inhibitor.	KEEP AS NON CORE	Summary: PMID:23516580 describes E. coli NleF effector as a caspase inhibitor that binds caspase-9. Reason: Pathogen effector binding is context-specific for microbial infection. Supporting Evidence: PMID:23516580 The E. coli effector protein NleF is a caspase inhibitor
GO:0005515 protein binding	IPI PMID:25241761 Using an in situ proximity ligation assay to systematically ...	KEEP AS NON CORE	Summary: High-throughput proximity ligation study. Reason: Large-scale study requiring validation of individual interactions. Supporting Evidence: PMID:25241761 Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions
GO:0005515 protein binding	IPI PMID:25416956 A proteome-scale map of the human interactome network.	KEEP AS NON CORE	Summary: Proteome-scale interactome mapping study. Reason: High-throughput study. Individual interactions need validation. Supporting Evidence: PMID:25416956 A proteome-scale map of the human interactome network
GO:0005515 protein binding	IPI PMID:25502805 A massively parallel pipeline to clone DNA variants and exam...	KEEP AS NON CORE	Summary: Massively parallel cloning and phenotyping study. Reason: High-throughput study. Supporting Evidence: PMID:25502805 A massively parallel pipeline to clone DNA variants and examine molecular phenotypes
GO:0005515 protein binding	IPI PMID:25519916 The EHEC-host interactome reveals novel targets for the tran...	KEEP AS NON CORE	Summary: EHEC-host interactome study identifying translocated intimin receptor targets. Reason: Pathogen-host interaction context. Supporting Evidence: PMID:25519916 The EHEC-host interactome reveals novel targets for the translocated intimin receptor
GO:0005515 protein binding	IPI PMID:27107012 Pooled-matrix protein interaction screens using Barcode Fusi...	KEEP AS NON CORE	Summary: Barcode Fusion Genetics protein interaction screen. Reason: High-throughput screening method. Supporting Evidence: PMID:27107012 Pooled-matrix protein interaction screens using Barcode Fusion Genetics
GO:0005515 protein binding	IPI PMID:29997244 LuTHy: a double-readout bioluminescence-based two-hybrid tec...	KEEP AS NON CORE	Summary: LuTHy two-hybrid technology for protein interaction mapping. Reason: High-throughput interaction mapping study. Supporting Evidence: PMID:29997244 LuTHy: a double-readout bioluminescence-based two-hybrid technology
GO:0005515 protein binding	IPI PMID:31467278 Maximizing binary interactome mapping with a minimal number ...	KEEP AS NON CORE	Summary: Binary interactome mapping optimization study. Reason: Methodological study for interaction mapping. Supporting Evidence: PMID:31467278 Maximizing binary interactome mapping with a minimal number of assays
GO:0005515 protein binding	IPI PMID:31515488 Extensive disruption of protein interactions by genetic vari...	KEEP AS NON CORE	Summary: Study of protein interaction disruption by genetic variants. Reason: Population genetics study of interaction disruption. Supporting Evidence: PMID:31515488 Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum
GO:0005515 protein binding	IPI PMID:32296183 A reference map of the human binary protein interactome.	KEEP AS NON CORE	Summary: Reference map of human binary protein interactome. Reason: Large-scale interactome reference study. Supporting Evidence: PMID:32296183 A reference map of the human binary protein interactome
GO:0005515 protein binding	IPI PMID:9390557 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-...	ACCEPT	Summary: PMID:9390557 is a landmark paper demonstrating caspase-9/Apaf-1 CARD-CARD interaction in apoptosome formation. Reason: Foundational paper on caspase-9 function. Demonstrates the core CARD-CARD interaction with Apaf-1 essential for apoptosome formation and caspase activation. Supporting Evidence: PMID:9390557 Caspase-9 and Apaf-1 bind to each other via their respective NH2-terminal CED-3 homologous domains in the presence of cytochrome c and dATP
GO:0005515 protein binding	IPI PMID:9922454 Ordering the cytochrome c-initiated caspase cascade: hierarc...	ACCEPT	Summary: PMID:9922454 describes the caspase cascade with caspase-9 dependent activation of downstream caspases. Reason: Demonstrates caspase-9 interaction with and processing of downstream caspases (caspase-2, -3, -6, -7, -8, -10). Core function of initiator caspase. Supporting Evidence: PMID:9922454 Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
GO:0001666 response to hypoxia	IEA GO_REF:0000107	ACCEPT	Summary: Caspase-9 is activated during hypoxia-induced apoptosis. Recent research shows non-apoptotic endothelial caspase-9 signaling in hypoxia-ischemia. Reason: Deep research confirms: "In a mouse model of retinal vein occlusion (RVO), pharmacological inhibition or genetic deletion of caspase-9 specifically from endothelial cells significantly reduces vascular edema." Hypoxia triggers intrinsic apoptotic pathway. Supporting Evidence: deep-research endothelial caspase-9 activation following hypoxia-ischemia appears to occur independently of apoptosis
GO:0001822 kidney development	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Caspase-mediated apoptosis plays roles in kidney development. This is a pleiotropic developmental process. Reason: Apoptosis is involved in kidney development but this is not a core function of caspase-9. The annotation is from ortholog transfer (Ensembl Compara). Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0002931 response to ischemia	IEA GO_REF:0000107	ACCEPT	Summary: Caspase-9 is activated in ischemic injury, both through apoptotic and non-apoptotic mechanisms in endothelial cells. Reason: Deep research confirms: "In a mouse model of retinal vein occlusion (RVO), pharmacological inhibition or genetic deletion of caspase-9...significantly reduces vascular edema, restores vascular integrity, and provides robust neuroprotection." Supporting Evidence: deep-research non-apoptotic endothelial caspase-9 signaling as a critical mediator of ischemic injury in hypoxia-ischemia models
GO:0005634 nucleus	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Nuclear localization of caspase-9 is less well-established than cytosolic localization. Some reports suggest translocation during apoptosis. Reason: Caspase-9 is primarily cytosolic. Nuclear localization may occur in specific contexts but is not the primary site of function. The annotation is from ortholog transfer and should be viewed with caution. Supporting Evidence: PMID:12782307 caspase-9 is in the cytoplasm of non-apoptotic pituitary cells
GO:0005737 cytoplasm	IEA GO_REF:0000107	ACCEPT	Summary: Cytoplasmic localization is well-established. Redundant with IBA annotation. Reason: Consistent with IBA annotation and experimental evidence. Caspase-9 is predominantly cytoplasmic. Supporting Evidence: PMID:12782307 caspase-9 is in the cytoplasm of non-apoptotic pituitary cells
GO:0005829 cytosol	IEA GO_REF:0000120	ACCEPT	Summary: Cytosolic localization confirmed. Redundant with IBA and TAS annotations. Reason: Consistent with other annotations and experimental evidence. Supporting Evidence: PMID:12782307 caspase-9 is in the cytoplasm of non-apoptotic pituitary cells
GO:0016485 protein processing	IEA GO_REF:0000107	ACCEPT	Summary: Caspase-9 processes procaspases-3 and -7 by proteolytic cleavage. This is a core function. Reason: Caspase-9 processes its substrates (procaspase-3, procaspase-7) to their mature forms. This is the primary enzymatic function. Supporting Evidence: PMID:16352606 Apaf-1 oligomerizes to produce approximately 1.4-MDa and approximately 700-kDa apoptosome complexes, and the latter complex directly cleaves/activates procaspase-7
GO:0032025 response to cobalt ion	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Cobalt ions can induce hypoxia-like responses. Caspase-9 may be activated in this context. Reason: Cobalt-induced response is likely through hypoxia mimicry. Not a core function but an experimental context. Annotation from ortholog transfer. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0032355 response to estradiol	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Estradiol can have anti-apoptotic effects that may involve caspase regulation. Reason: Hormone response is context-specific. Annotation from ortholog transfer. Not a core function. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0032496 response to lipopolysaccharide	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: LPS can trigger apoptotic pathways in various cell types. Reason: LPS response is context-specific, particularly relevant to immune cells. Annotation from ortholog transfer. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0034349 glial cell apoptotic process	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Caspase-9 is involved in glial cell apoptosis as part of CNS development and disease. Reason: Cell-type specific apoptotic process. Not a core function but consistent with caspase-9's role in CNS development. CRITICAL: Only isoform 1 would positively regulate this. Supporting Evidence: deep-research mice lacking caspase-9 die perinatally with severe brain abnormalities
GO:0043065 positive regulation of apoptotic process	IEA GO_REF:0000120	ACCEPT	Summary: CRITICAL ISOFORM ANNOTATION: This annotation is ONLY true for isoform 1 (Caspase-9L/Alpha). Isoform 2 (Caspase-9S/Beta) is a DOMINANT-NEGATIVE INHIBITOR that NEGATIVELY regulates apoptosis. Reason: Isoform 1 does positively regulate apoptosis by activating effector caspases. However, the annotation should ideally be isoform-specific. The IEA annotation applies to the canonical pro-apoptotic function. Supporting Evidence: PMID:9390557 caspase-9 is the most upstream member of the apoptotic protease cascade deep-research the pro-apoptotic caspase-9a that retains exons 3, 4, 5, and 6, and the anti-apoptotic caspase-9b
GO:0045471 response to ethanol	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Ethanol can induce apoptosis in various tissues including liver and neurons. Reason: Toxicological response context. Annotation from ortholog transfer. Not a core function. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0071549 cellular response to dexamethasone stimulus	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Dexamethasone can induce apoptosis in some cell types. Reason: Glucocorticoid response is context-specific. Annotation from ortholog transfer. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0071680 response to indole-3-methanol	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Indole-3-carbinol is a phytochemical that can affect apoptotic pathways. Reason: Specific chemical response. Not a core function. Annotation from ortholog transfer. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0071887 leukocyte apoptotic process	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Caspase-9 is involved in leukocyte apoptosis as part of immune regulation. Reason: Cell-type specific apoptotic process. The intrinsic pathway operates in leukocytes but this is not a core function annotation. CRITICAL: Only isoform 1 promotes this. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0072347 response to anesthetic	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: Some anesthetics can induce neuronal apoptosis involving caspase-9. Reason: Specific pharmacological context. Annotation from ortholog transfer. Supporting Evidence: GO_REF:0000107 Automatic transfer of experimentally verified manual GO annotation data to orthologs
GO:0004197 cysteine-type endopeptidase activity	TAS Reactome:R-HSA-114259	ACCEPT	Summary: Reactome pathway annotation for caspase-9 cleavage. CRITICAL: This catalytic activity is ONLY present in isoform 1. Reason: Reactome correctly annotates the catalytic activity in the context of apoptosome-mediated procaspase-9 cleavage to active caspase-9. Supporting Evidence: Reactome:R-HSA-114259 Procaspase‑9 is processed in an ATP‑dependent manner following association with APAF1 and cytochrome c (CYCS) within the apoptosome complex
GO:0097193 intrinsic apoptotic signaling pathway	NAS PMID:10206961 An APAF-1.cytochrome c multimeric complex is a functional ap...	ACCEPT	Summary: PMID:10206961 demonstrates caspase-9 activation in the apoptosome as the key step in the intrinsic apoptotic pathway. CRITICAL: Isoform 1 activates while isoform 2 inhibits this pathway. Reason: Core annotation for caspase-9 function. The paper demonstrates apoptosome formation and procaspase-9 activation. Supporting Evidence: PMID:10206961 Such a complex can be isolated using gel filtration chromatography and is by itself sufficient to recruit and activate procaspase-9
GO:0004197 cysteine-type endopeptidase activity	IDA PMID:16352606 Caspase-7 is directly activated by the approximately 700-kDa...	ACCEPT	Summary: PMID:16352606 demonstrates caspase-9 directly cleaving and activating caspase-7 in the apoptosome. This is direct experimental evidence for the catalytic activity (isoform 1 only). Reason: Direct experimental demonstration of caspase-9 enzymatic activity in processing caspase-7. Supporting Evidence: PMID:16352606 Apaf-1 oligomerizes to produce approximately 1.4-MDa and approximately 700-kDa apoptosome complexes, and the latter complex directly cleaves/activates procaspase-7
GO:0004197 cysteine-type endopeptidase activity	IDA PMID:16916640 Engineered hybrid dimers: tracking the activation pathway of...	ACCEPT	Summary: PMID:16916640 uses engineered hybrid dimers to track caspase-7 activation by caspase-9, demonstrating the endopeptidase activity (isoform 1). Reason: Direct experimental demonstration of caspase-9 enzymatic activity in processing caspase-7 using sophisticated biochemical approaches. Supporting Evidence: PMID:16916640 A transient intermediate of singly cleaved dimeric caspase-7 can be found in a cell-free model of apoptosis induction
GO:0043065 positive regulation of apoptotic process	IMP PMID:11821383 CARD-8 protein, a new CARD family member that regulates casp...	ACCEPT	Summary: PMID:11821383 describes CARD-8 interaction with caspase-9. The paper shows CARD-8 overexpression induces apoptosis. CRITICAL: This pro-apoptotic function is isoform 1 specific. Reason: The study demonstrates caspase-9's role in apoptosis induction through CARD-domain interactions. The mutant phenotype evidence supports positive regulation of apoptosis. Supporting Evidence: PMID:11821383 Overexpression of CARD-8 can also induce apoptosis in transfected cells
GO:0006974 DNA damage response	IMP PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in th...	ACCEPT	Summary: PMID:15657060 demonstrates c-Abl phosphorylates caspase-9 in DNA damage response, with mutant phenotype evidence. Reason: Direct experimental evidence using Y153F mutant showing attenuated DNA damage-induced caspase-9 processing and apoptosis. Supporting Evidence: PMID:15657060 Caspase-9(Y153F) also attenuated DNA damage-induced processing of caspase-9 to p35, activation of caspase-3, and apoptosis
GO:0005829 cytosol	TAS Reactome:R-HSA-9627089	ACCEPT	Summary: Reactome pathway annotation for caspase-9 localization in phosphorylation reaction. Reason: Consistent with other cytosolic localization annotations. Caspase-9 is phosphorylated at T412 in the cytosol. Supporting Evidence: Reactome:R-HSA-9627089 CASP9 is phosphorylated at T412
GO:0097193 intrinsic apoptotic signaling pathway	IDA PMID:35446120 Calmodulin Binding Activates Chromobacterium CopC Effector t...	ACCEPT	Summary: PMID:35446120 shows Chromobacterium CopC effector ADP-riboxanates caspase-9 to inhibit intrinsic apoptotic pathway. This demonstrates caspase-9's role in the pathway (isoform 1). Reason: The study demonstrates caspase-9's essential role in intrinsic apoptotic signaling by showing that pathogen effector modification blocks this pathway. Supporting Evidence: PMID:35446120 Calmodulin Binding Activates Chromobacterium CopC Effector to ADP-Riboxanate Host Apoptotic Caspases
GO:0005739 mitochondrion	IDA PMID:12782307 Apoptosis triggered redistribution of caspase-9 from cytopla...	ACCEPT	Summary: PMID:12782307 shows caspase-9 redistributes from cytoplasm to mitochondria during apoptosis. Reason: Direct experimental evidence of caspase-9 mitochondrial localization during apoptosis. The paper shows "activation of apoptosis with rotenone triggers the redistribution of caspase-9 to mitochondria." Supporting Evidence: PMID:12782307 The activation of apoptosis with rotenone triggers the redistribution of caspase-9 to mitochondria
GO:0004197 cysteine-type endopeptidase activity	IDA PMID:27889207 Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apopto...	ACCEPT	Summary: PMID:27889207 demonstrates PAK2 phosphorylation of caspase-7 blocks its activation by caspase-9, providing evidence for caspase-9 enzymatic activity (isoform 1). Reason: The study demonstrates caspase-9's enzymatic activity in caspase-7 activation. Supporting Evidence: PMID:27889207 Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms
GO:0051604 protein maturation	IDA PMID:16352606 Caspase-7 is directly activated by the approximately 700-kDa...	ACCEPT	Summary: PMID:16352606 shows caspase-9 directly matures procaspase-7 to active caspase-7 (isoform 1 function). Reason: Direct experimental evidence of caspase-9 processing procaspase-7 to mature enzyme. Supporting Evidence: PMID:16352606 Apaf-1 oligomerizes to produce approximately 1.4-MDa and approximately 700-kDa apoptosome complexes, and the latter complex directly cleaves/activates procaspase-7
GO:0051604 protein maturation	IDA PMID:16916640 Engineered hybrid dimers: tracking the activation pathway of...	ACCEPT	Summary: PMID:16916640 demonstrates caspase-7 maturation by caspase-9 using hybrid dimers (isoform 1 function). Reason: Direct experimental evidence using sophisticated biochemical approaches to demonstrate procaspase-7 maturation. Supporting Evidence: PMID:16916640 The processed domain of this singly cleaved zymogen has the same catalytic activity as a domain of fully active caspase-7
GO:1900119 positive regulation of execution phase of apoptosis	IDA PMID:16916640 Engineered hybrid dimers: tracking the activation pathway of...	ACCEPT	Summary: PMID:16916640 demonstrates caspase-9 activates caspase-7, which executes apoptosis. CRITICAL: This is isoform 1 specific. Reason: The execution phase of apoptosis is triggered by activation of executioner caspases (caspase-3 and -7) by caspase-9. Direct experimental evidence. Supporting Evidence: PMID:16916640 Our study demonstrates the efficiency by which the executioner caspases are activated in vivo
GO:0004197 cysteine-type endopeptidase activity	IMP PMID:21980415 Identification of a conserved anti-apoptotic protein that mo...	ACCEPT	Summary: PMID:21980415 identifies conserved anti-apoptotic protein modulating mitochondrial apoptosis pathway, using mutant phenotypes to demonstrate caspase-9 activity. Reason: Mutant phenotype evidence for caspase-9 catalytic activity in apoptosis. Supporting Evidence: PMID:21980415 Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway
GO:0006915 apoptotic process	IMP PMID:15069058 BRCC2, a novel BH3-like domain-containing protein, induces a...	ACCEPT	Summary: PMID:15069058 describes BRCC2, a BH3-domain protein that induces apoptosis in a caspase-dependent manner. Reason: Mutant phenotype evidence for caspase-9 role in apoptosis through BH3 domain protein interactions. Supporting Evidence: PMID:15069058 BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in a caspase-dependent manner
GO:0004197 cysteine-type endopeptidase activity	IDA PMID:16920334 Protective role of Cop in Rip2/caspase-1/caspase-4-mediated ...	ACCEPT	Summary: PMID:16920334 examines Cop protective role in caspase-mediated cell death (isoform 1 function). Reason: Direct assay evidence for caspase-9 catalytic activity in cell death. Supporting Evidence: PMID:16920334 Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death
GO:0005515 protein binding	IPI PMID:11821383 CARD-8 protein, a new CARD family member that regulates casp...	KEEP AS NON CORE	Summary: PMID:11821383 shows CARD-8 binds to caspase-9 via CARD domain interaction. Reason: CARD domain interaction is documented but "protein binding" is uninformative. The CARD-CARD interaction is regulatory. Supporting Evidence: PMID:11821383 CARD-8 binds also to ICEBERG and pseudo-ICE
GO:0032991 protein-containing complex	IDA PMID:11821383 CARD-8 protein, a new CARD family member that regulates casp...	KEEP AS NON CORE	Summary: PMID:11821383 identifies caspase-9 in protein complexes with CARD-8. Reason: Generic complex annotation. The apoptosome is the key functional complex for caspase-9. Supporting Evidence: PMID:11821383 CARD-8 interacts physically with caspase-1
GO:0008233 peptidase activity	IDA PMID:19740745 A truncated form of p23 down-regulates telomerase activity v...	ACCEPT	Summary: PMID:19740745 shows truncated p23 disrupts Hsp90 function affecting telomerase. Caspase-9 peptidase activity is involved (isoform 1). Reason: Direct assay evidence for caspase-9 peptidase activity. Parent term of cysteine-type endopeptidase activity. Supporting Evidence: PMID:19740745 A truncated form of p23 down-regulates telomerase activity via disruption of Hsp90 function
GO:0005515 protein binding	IPI PMID:19255499 HIP1R interacts with a member of Bcl-2 family, BCL2L10, and ...	KEEP AS NON CORE	Summary: PMID:19255499 shows HIP1R interacts with BCL2L10 which affects BAK-dependent cell death. Reason: BCL2L10 interaction affects mitochondrial apoptosis pathway. Regulatory interaction. Supporting Evidence: PMID:19255499 HIP1R interacts with a member of Bcl-2 family, BCL2L10, and induces BAK-dependent cell death
GO:0005829 cytosol	TAS Reactome:R-HSA-114252	ACCEPT	Summary: Reactome pathway annotation for procaspase-3 cleavage by apoptosome. Reason: Consistent with cytosolic localization of the apoptosome complex where caspase-9 cleaves procaspase-3. Supporting Evidence: Reactome:R-HSA-114252 Cleavage of Procaspase-3 by the apoptosome
GO:0005829 cytosol	TAS Reactome:R-HSA-114259	ACCEPT	Summary: Reactome annotation for procaspase-9 cleavage. Reason: Consistent with cytosolic localization of the apoptosome. Supporting Evidence: Reactome:R-HSA-114259 Procaspase‑9 is processed in an ATP‑dependent manner following association with APAF1 and cytochrome c (CYCS) within the apoptosome complex
GO:0005829 cytosol	TAS Reactome:R-HSA-114261	ACCEPT	Summary: Reactome annotation for procaspase-7 cleavage by apoptosome. Reason: Consistent with cytosolic localization. Supporting Evidence: Reactome:R-HSA-114261 Cleavage of Procaspase-7 by the apoptosome
GO:0005829 cytosol	TAS Reactome:R-HSA-373700	ACCEPT	Summary: Reactome annotation for caspase-9 binding to DCC:DIP13alpha complex. Reason: Consistent with cytosolic localization for dependence receptor signaling. Supporting Evidence: Reactome:R-HSA-373700 Caspase-9 binds DCC:DIP13alpha complex
GO:0005829 cytosol	TAS Reactome:R-HSA-418845	ACCEPT	Summary: Reactome annotation for caspase-3 activation. Reason: Consistent with cytosolic localization for caspase cascade. Supporting Evidence: Reactome:R-HSA-418845 Activation of caspase-3
GO:0005829 cytosol	TAS Reactome:R-HSA-6804596	ACCEPT	Summary: Reactome annotation for APAF1:CYCS binding APIP. Reason: Consistent with cytosolic localization of apoptosome components. Supporting Evidence: Reactome:R-HSA-6804596 APAF1:CYCS binds APIP
GO:0005829 cytosol	TAS Reactome:R-HSA-6805426	ACCEPT	Summary: Reactome annotation for CARD8 binding to CASP9(1-416). Reason: Consistent with cytosolic localization. Supporting Evidence: Reactome:R-HSA-6805426 CARD8 binds CASP9(1-416)
GO:0005829 cytosol	TAS Reactome:R-HSA-9627056	ACCEPT	Summary: Reactome annotation for procaspase-9 dimer formation. Reason: Consistent with cytosolic localization for dimerization. Supporting Evidence: Reactome:R-HSA-9627056 Procaspase 9 forms dimer
GO:0005829 cytosol	TAS Reactome:R-HSA-9627078	ACCEPT	Summary: Reactome annotation for XIAP binding CASP9. Reason: Consistent with cytosolic localization for IAP regulation. Supporting Evidence: Reactome:R-HSA-9627078 X‑linked inhibitor‑of‑apoptosis protein (XIAP) associates with the cleaved form of CASP9
GO:0005829 cytosol	IDA PMID:17167422 Hsp70 regulates erythropoiesis by preventing caspase-3-media...	ACCEPT	Summary: PMID:17167422 shows Hsp70 regulates erythropoiesis by preventing caspase-3 cleavage of GATA-1 in the cytosol. Reason: Direct experimental evidence for cytosolic caspase activity during erythroid differentiation. Supporting Evidence: PMID:17167422 At the onset of caspase activation, Hsp70 co-localizes and interacts with GATA-1 in the nucleus
GO:0030220 platelet formation	TAS PMID:18309324 No death without life: vital functions of apoptotic effector...	KEEP AS NON CORE	Summary: PMID:18309324 reviews non-apoptotic functions of apoptotic effectors, including roles in platelet formation. Reason: Non-apoptotic function of caspases in platelet formation is documented. This represents a specialized function distinct from core apoptotic role. Supporting Evidence: PMID:18309324 multiple studies indicate that the mammalian orthologs of these C. elegans proteins (i.e. caspases, Apaf-1 and multidomain proteins of the Bcl-2 family) participate in cell death-unrelated processes
GO:0005829 cytosol	TAS Reactome:R-HSA-114256	ACCEPT	Summary: Reactome annotation for CYCS:APAF1 binding procaspase-9. Reason: Consistent with cytosolic localization of apoptosome assembly. Supporting Evidence: Reactome:R-HSA-114256 CYCS:APAF1 binds procaspase-9
GO:0005829 cytosol	TAS Reactome:R-HSA-198621	ACCEPT	Summary: Reactome annotation for AKT phosphorylates caspase-9. Reason: Consistent with cytosolic localization for AKT-mediated regulation. Supporting Evidence: Reactome:R-HSA-198621 AKT phosphorylates caspase-9
GO:0005829 cytosol	TAS Reactome:R-HSA-2399985	ACCEPT	Summary: Reactome annotation for AKT1 E17K mutant phosphorylates caspase-9. Reason: Consistent with cytosolic localization. Supporting Evidence: Reactome:R-HSA-2399985 AKT1 E17K mutant phosphorylates caspase-9
GO:0005829 cytosol	TAS Reactome:R-HSA-6804596	ACCEPT	Summary: Duplicate annotation - same as earlier entry. Reason: Consistent with cytosolic localization. Supporting Evidence: Reactome:R-HSA-6804596 APAF1:CYCS binds APIP
GO:0005829 cytosol	TAS Reactome:R-HSA-6805426	ACCEPT	Summary: Duplicate annotation - same as earlier entry. Reason: Consistent with cytosolic localization. Supporting Evidence: Reactome:R-HSA-6805426 CARD8 binds CASP9(1-416)
GO:0005829 cytosol	TAS Reactome:R-HSA-9627056	ACCEPT	Summary: Duplicate annotation - same as earlier entry. Reason: Consistent with cytosolic localization. Supporting Evidence: Reactome:R-HSA-9627056 Procaspase 9 forms dimer
GO:0005515 protein binding	IPI PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in th...	ACCEPT	Summary: PMID:15657060 shows c-Abl directly binds caspase-9 via SH3 domain. Reason: c-Abl/caspase-9 interaction is functionally important for DNA damage response. Though "protein binding" is vague, the interaction is core to DNA damage-induced apoptosis. Supporting Evidence: PMID:15657060 c-Abl binds directly to caspase-9
GO:0006974 DNA damage response	IDA PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in th...	ACCEPT	Summary: PMID:15657060 provides direct assay evidence for caspase-9 in DNA damage response through c-Abl-mediated phosphorylation. Reason: Direct experimental demonstration of caspase-9 activation in DNA damage response via c-Abl phosphorylation at Tyr-153. Supporting Evidence: PMID:15657060 c-Abl phosphorylates caspase-9 on Tyr-153 in vitro and in cells treated with DNA damaging agents
GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage	IMP PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in th...	ACCEPT	Summary: PMID:15657060 demonstrates Y153F mutant attenuates DNA damage-induced caspase-9 processing and apoptosis. Reason: Mutant phenotype evidence for caspase-9 role in intrinsic apoptotic signaling in response to DNA damage. Supporting Evidence: PMID:15657060 Caspase-9(Y153F) also attenuated DNA damage-induced processing of caspase-9 to p35, activation of caspase-3, and apoptosis
GO:0019901 protein kinase binding	IDA PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in th...	ACCEPT	Summary: PMID:15657060 demonstrates caspase-9 binds c-Abl tyrosine kinase. Reason: Direct experimental evidence for caspase-9 binding to c-Abl kinase. This is a more informative term than generic "protein binding". Supporting Evidence: PMID:15657060 c-Abl binds directly to caspase-9
GO:0034644 cellular response to UV	IDA PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in th...	ACCEPT	Summary: PMID:15657060 demonstrates caspase-9 activation in response to UV irradiation via c-Abl. Reason: Direct experimental evidence for caspase-9 role in UV response. The Y153F mutant attenuates UV irradiation-induced apoptosis. Supporting Evidence: PMID:15657060 Caspase-9(Y153F) also attenuated DNA damage-induced processing of caspase-9 to p35, activation of caspase-3, and apoptosis
GO:0042770 signal transduction in response to DNA damage	IDA PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in th...	ACCEPT	Summary: PMID:15657060 shows c-Abl-mediated signal transduction to caspase-9 in DNA damage response. Reason: Direct experimental evidence for caspase-9 role in DNA damage signal transduction through c-Abl kinase. Supporting Evidence: PMID:15657060 c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage
GO:0005515 protein binding	IPI PMID:11350957 Characterization of a novel proapoptotic caspase-2- and casp...	KEEP AS NON CORE	Summary: PMID:11350957 describes proapoptotic caspase-2 and caspase-9 binding protein. Reason: Documents a caspase-binding protein. "Protein binding" is uninformative. Supporting Evidence: PMID:11350957 Characterization of a novel proapoptotic caspase-2- and caspase-9-binding protein
GO:0043293 apoptosome	IDA PMID:21827945 The holo-apoptosome: activation of procaspase-9 and interact...	ACCEPT	Summary: PMID:21827945 provides structural evidence for caspase-9 as a component of the apoptosome. Reason: Key structural study demonstrating caspase-9 localization to the apoptosome. CRITICAL: Both isoforms can bind Apaf-1 in the apoptosome, but with opposite effects (isoform 1 activates cascade, isoform 2 inhibits). Supporting Evidence: PMID:21827945 Activation of procaspase-9 on the apoptosome is a pivotal step in the intrinsic cell death pathway
GO:0006915 apoptotic process	TAS PMID:8663294 ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is ac...	ACCEPT	Summary: PMID:8663294 is the original paper characterizing ICE-LAP6 (caspase-9) as an apoptosis-inducing caspase. Reason: Foundational paper demonstrating caspase-9 (ICE-LAP6) induces apoptosis when overexpressed and is activated by granzyme B. Supporting Evidence: PMID:8663294 Overexpression of ICE-LAP6 induces apoptosis in MCF7 breast carcinoma cells
GO:0005515 protein binding	IPI PMID:11069302 Regulation of apoptosis at cell division by p34cdc2 phosphor...	KEEP AS NON CORE	Summary: PMID:11069302 describes survivin interaction with caspase-9. Reason: Survivin is an IAP family member that regulates caspase-9 activity. Regulatory interaction. Supporting Evidence: PMID:11069302 Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
GO:0004197 cysteine-type endopeptidase activity	TAS PMID:9390557 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-...	ACCEPT	Summary: PMID:9390557 is the landmark paper demonstrating caspase-9 catalytic activity in the intrinsic pathway (isoform 1). Reason: Foundational paper demonstrating caspase-9 cleaves and activates caspase-3. Supporting Evidence: PMID:9390557 Activated caspase-9 in turn cleaves and activates caspase-3
GO:0008047 enzyme activator activity	TAS PMID:9390557 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-...	ACCEPT	Summary: PMID:9390557 demonstrates caspase-9 activates caspase-3 (isoform 1 function). Reason: Caspase-9 functions as an enzyme activator by cleaving and activating downstream effector caspases. This captures the initiator caspase function. Supporting Evidence: PMID:9390557 Activated caspase-9 in turn cleaves and activates caspase-3
GO:0043066 negative regulation of apoptotic process	TAS PMID:10070954 Identification of an endogenous dominant-negative short isof...	NEW	Summary: MISSING ANNOTATION: Caspase-9S (isoform 2, P55211-2) is a dominant-negative inhibitor of apoptosis. UniProt explicitly states "Isoform 2: Lacks activity is an dominant-negative inhibitor of caspase-9." This annotation is CRITICAL for understanding CASP9 biology. Reason: Isoform 2 (Caspase-9S/Beta) lacks the catalytic domain and competes with isoform 1 for Apaf-1 binding, thereby inhibiting apoptosis. This is a dominant-negative mechanism where the 9L/9S ratio determines apoptotic sensitivity. PMID:10070954 characterizes this isoform. Cancer cells often shift ratio towards 9S to evade apoptosis. Supporting Evidence: PMID:10070954 Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis deep-research the anti-apoptotic caspase-9b that excludes these exons...caspase-9b lacks the core catalytic domain and functions as a dominant-negative inhibitor of caspase-9a
GO:0030234 enzyme regulator activity	NAS	NEW	Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: PMID:10070954 Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis

Core Functions

Initiator caspase of the intrinsic (mitochondrial) apoptotic pathway. Upon mitochondrial outer membrane permeabilization (MOMP) and cytochrome c release, caspase-9 (isoform 1) is recruited to the Apaf-1 apoptosome via CARD-CARD interactions, where it is activated and cleaves/activates effector caspases-3 and -7 to execute apoptosis.

Molecular Function:

cysteine-type endopeptidase activity

Directly Involved In:

intrinsic apoptotic signaling pathway

Cellular Locations:

apoptosome

Cysteine-type endopeptidase with strict requirement for Asp at P1 position and preference for LEHD sequence. Cleaves procaspase-3 and procaspase-7 at their intersubunit linkers to generate active executioner caspases.

Molecular Function:

cysteine-type endopeptidase activity

Substrates:

CASP3 CASP7

DNA damage response effector: c-Abl kinase phosphorylates caspase-9 at Tyr-153 in response to genotoxic stress, promoting caspase-9 autoprocessing and apoptosis.

Molecular Function:

cysteine-type endopeptidase activity

Directly Involved In:

intrinsic apoptotic signaling pathway in response to DNA damage

CRITICAL ISOFORM BIOLOGY: Alternative splicing produces antagonistic isoforms. Isoform 1 (Caspase-9L/9a/Alpha) is pro-apoptotic with full catalytic activity. Isoform 2 (Caspase-9S/9b/Beta) lacks the catalytic domain and acts as a DOMINANT-NEGATIVE INHIBITOR by competing for Apaf-1 binding. The 9L/9S ratio determines cellular apoptotic sensitivity.

Molecular Function:

enzyme regulator activity

Supporting Evidence:

PMID:10070954
Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:10070954

Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis.

Caspase-9S (isoform 2) lacks catalytic domain and acts as dominant-negative inhibitor

PMID:10206961

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9.

Apoptosome recruits and activates procaspase-9
Stoichiometric ratio of procaspase-9 to APAF-1 is approximately 1 to 1

PMID:10376594

Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1.

CARD-CARD interaction between caspase-9 and Apaf-1

PMID:11024045

Livin, a novel inhibitor of apoptosis protein family member.

PMID:11069302

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

PMID:11084335

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

PMID:11230124

Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes.

PMID:11242052

A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.

PMID:11350957

Characterization of a novel proapoptotic caspase-2- and caspase-9-binding protein.

PMID:11801603

SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP).

PMID:11821383

CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis.

PMID:12620238

Mechanism of XIAP-mediated inhibition of caspase-9.

PMID:12782307

Apoptosis triggered redistribution of caspase-9 from cytoplasm to mitochondria.

Caspase-9 is cytoplasmic in non-apoptotic cells
Redistributes to mitochondria during apoptosis

PMID:15069058

BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in a caspase-dependent manner.

PMID:15657060

c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage.

c-Abl directly binds caspase-9
Phosphorylates caspase-9 at Tyr-153 in DNA damage response
Y153F mutant attenuates DNA damage-induced apoptosis

PMID:16189514

Towards a proteome-scale map of the human protein-protein interaction network.

PMID:16352606

Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex.

Apoptosome directly cleaves/activates procaspase-7

PMID:16537496

The dependence receptor DCC requires lipid raft localization for cell death signaling.

PMID:16916640

Engineered hybrid dimers: tracking the activation pathway of caspase-7.

Demonstrates caspase-9 activation of caspase-7

PMID:16920334

Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death.

PMID:16936772

Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells.

PMID:17167422

Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1.

PMID:18022362

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

PMID:18309324

No death without life: vital functions of apoptotic effectors.

Caspases have non-apoptotic functions including platelet formation

PMID:18723680

Executioner caspase-3 and caspase-7 are functionally distinct proteases.

PMID:19153467

The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.

PMID:19255499

HIP1R interacts with a member of Bcl-2 family, BCL2L10, and induces BAK-dependent cell death.

PMID:19494828

The Apaf-1*procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer.

PMID:19721007

Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression.

PMID:19740745

A truncated form of p23 down-regulates telomerase activity via disruption of Hsp90 function.

PMID:20462491

Structure of an apoptosome-procaspase-9 CARD complex.

PMID:21827945

The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3.

Structural evidence for caspase-9 in apoptosome

PMID:21980415

Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway.

PMID:23516580

The E. coli effector protein NleF is a caspase inhibitor.

PMID:25241761

Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.

PMID:25416956

A proteome-scale map of the human interactome network.

PMID:25502805

A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations.

PMID:25519916

The EHEC-host interactome reveals novel targets for the translocated intimin receptor.

PMID:27107012

Pooled-matrix protein interaction screens using Barcode Fusion Genetics.

PMID:27889207

Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms.

PMID:29997244

LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.

PMID:31467278

Maximizing binary interactome mapping with a minimal number of assays.

PMID:31515488

Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.

PMID:32296183

A reference map of the human binary protein interactome.

PMID:35446120

Calmodulin Binding Activates Chromobacterium CopC Effector to ADP-Riboxanate Host Apoptotic Caspases.

PMID:8663294

ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B.

Original characterization of caspase-9 (ICE-LAP6)
Overexpression induces apoptosis

PMID:9390557

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Landmark paper establishing caspase-9 as initiator caspase
CARD-CARD interaction with Apaf-1
Activates caspase-3

PMID:9922454

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

Reactome:R-HSA-114252

Cleavage of Procaspase-3 by the apoptosome

Reactome:R-HSA-114256

CYCS:APAF1 binds procaspase-9

Reactome:R-HSA-114259

Cleavage of Procaspase‑9 to caspase‑9

Reactome:R-HSA-114261

Cleavage of Procaspase-7 by the apoptosome

Reactome:R-HSA-198621

AKT phosphorylates caspase-9

Reactome:R-HSA-2399985

AKT1 E17K mutant phosphorylates caspase-9

Reactome:R-HSA-373700

Caspase-9 binds DCC:DIP13alpha complex

Reactome:R-HSA-418845

Activation of caspase-3

Reactome:R-HSA-6804596

APAF1:CYCS binds APIP

Reactome:R-HSA-6805426

CARD8 binds CASP9(1-416)

Reactome:R-HSA-9627056

Procaspase 9 forms dimer

Reactome:R-HSA-9627078

XIAP binds CASP9

Reactome:R-HSA-9627089

CASP9 is phosphorylated at T412

file:human/CASP9/CASP9-deep-research-perplexity.md

Deep research report on CASP9

Suggested Experiments

Experiment: Isoform-specific proteomics: Develop isoform-specific antibodies or mass spectrometry methods to quantify 9L/9S ratios across tissues and disease states.

Experiment: Structural studies of Caspase-9S in the apoptosome: Determine how the truncated isoform interacts with Apaf-1 and whether it truly occupies the same binding site as 9L.

Experiment: Conditional isoform knockout: Generate mice with isoform-specific knockouts to determine the specific physiological roles of each isoform.

📚 Additional Documentation

Deep Research Perplexity

(CASP9-deep-research-perplexity.md)

provider: perplexity
model: sonar-deep-research
cached: false
start_time: '2026-01-19T08:03:11.790165'
end_time: '2026-01-19T08:05:26.281015'
duration_seconds: 134.49
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: CASP9
gene_symbol: CASP9
uniprot_accession: P55211
protein_description: 'RecName: Full=Caspase-9; Short=CASP-9; EC=3.4.22.62 {ECO:0000269|PubMed:16916640,
ECO:0000269|PubMed:23516580, ECO:0000269|PubMed:27889207}; AltName: Full=Apoptotic
protease Mch-6; AltName: Full=Apoptotic protease-activating factor 3; Short=APAF-3;
AltName: Full=ICE-like apoptotic protease 6; Short=ICE-LAP6; Contains: RecName:
Full=Caspase-9 subunit p35; Contains: RecName: Full=Caspase-9 subunit p10; Flags:
Precursor;'
gene_info: Name=CASP9; Synonyms=MCH6;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the peptidase C14A family. .
protein_domains: CARD. (IPR001315); CARD_CASP9. (IPR042147); Caspase-like_dom_sf.
(IPR029030); Caspase_cys_AS. (IPR033139); Caspase_his_AS. (IPR016129)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
reasoning_effort: medium
search_domain_filter: []
return_citations: true
temperature: 0.0
citation_count: 52

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: P55211
Protein Description: RecName: Full=Caspase-9; Short=CASP-9; EC=3.4.22.62 {ECO:0000269|PubMed:16916640, ECO:0000269|PubMed:23516580, ECO:0000269|PubMed:27889207}; AltName: Full=Apoptotic protease Mch-6; AltName: Full=Apoptotic protease-activating factor 3; Short=APAF-3; AltName: Full=ICE-like apoptotic protease 6; Short=ICE-LAP6; Contains: RecName: Full=Caspase-9 subunit p35; Contains: RecName: Full=Caspase-9 subunit p10; Flags: Precursor;
Gene Information: Name=CASP9; Synonyms=MCH6;
Organism (full): Homo sapiens (Human).
Protein Family: Belongs to the peptidase C14A family. .
Key Domains: CARD. (IPR001315); CARD_CASP9. (IPR042147); Caspase-like_dom_sf. (IPR029030); Caspase_cys_AS. (IPR033139); Caspase_his_AS. (IPR016129)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "CASP9" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'CASP9' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene CASP9 (gene ID: CASP9, UniProt: P55211) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Comprehensive Functional Analysis of Human Caspase-9 (CASP9): Structure, Mechanisms, and Biological Roles

Caspase-9, encoded by the CASP9 gene (UniProt: P55211), stands as one of the most intensively studied initiator caspases and represents a critical hub in cellular decision-making between life and death[1][7]. As a 416-residue cysteine-aspartic protease belonging to the peptidase C14A family, caspase-9 serves as a pivotal molecular switch that initiates the intrinsic or mitochondrial apoptotic pathway in response to diverse cellular stressors including chemotherapy, DNA damage, oxidative stress, and radiation[1][4]. Beyond its canonical role in triggering programmed cell death, emerging evidence demonstrates that caspase-9 executes sophisticated non-apoptotic functions that influence mitochondrial homeostasis, autophagy regulation, immune responses, vascular integrity, and synaptic plasticity[14][35][36]. This multifaceted protease achieves remarkable selectivity in its enzymatic activity and is subject to intricate multilayered regulation through phosphorylation, alternative splicing, protein-protein interactions, and allosteric mechanisms, positioning it as a central node in cellular physiology with profound implications for cancer biology, neurodegeneration, developmental processes, and therapeutic intervention.

Molecular Structure and Domain Organization of Caspase-9

Structural Architecture and Functional Domains

Caspase-9 possesses a distinctive modular architecture that fundamentally shapes its regulatory properties and distinguishes it from other members of the caspase family[1][5][10]. The protein comprises several functionally discrete domains organized in a linear fashion: an N-terminal caspase activation and recruitment domain (CARD) spanning residues 1 to 92, a long and disordered linker region connecting residues 93 to 138, a protease domain subdivided into two subunits designated p20 (residues 139 to 289) and p10 (residues 341 to 416), and another lengthy disordered linker connecting the p20 and p10 subunits (residues 290 to 340)[5][10]. The CARD domain functions as a dedicated protein interaction module that facilitates homotypic interactions with the CARD present in apoptotic protease-activating factor 1 (Apaf-1), thereby serving as the primary recruitment mechanism by which caspase-9 becomes tethered to the apoptosome complex[1][20]. This CARD-CARD interaction represents a paradigmatic example of death domain superfamily protein-protein recognition, involving complementary electrostatic interfaces formed between positively charged helices in the caspase-9 CARD and negatively charged helices in the Apaf-1 CARD[20].

The protease domain of caspase-9 contains the catalytic machinery required for proteolytic cleavage of downstream substrates[1][5]. Within the active site resides a cysteine-histidine catalytic dyad, with cysteine-287 serving as the nucleophilic catalyst and histidine-237 functioning as the general base facilitator[5][10]. Structural analysis reveals that the active site contains four highly mobile loops that must achieve a properly ordered conformation to establish substrate-binding competency[10][53]. A striking feature distinguishing caspase-9 from most other executioner caspases is the presence of long disordered linker regions that physically separate the CARD from the catalytic core, which creates unusual regulatory properties and prevents caspase-9 from existing constitutively as a dimeric enzyme in solution[5][10].

The Inhibitory Role of the CARD Domain

Unexpectedly, extensive mechanistic studies have revealed that the caspase-9 CARD domain actually functions as an allosteric inhibitor of the protease domain's catalytic activity[5][53]. When the CARD is present, isolated protease domain fragments exhibit substantially higher proteolytic activity compared to full-length caspase-9 in solution[5]. This counter-intuitive regulatory architecture appears to serve as a fail-safe mechanism preventing inappropriate activation of caspase-9 in the cytosol[5][10]. Removal of the CARD and linker sequences (residues 1 to 138) increases caspase-9 activity by at least 10-fold in peptide-based assays, indicating that sequential regions of the prodomain exert cumulative inhibitory effects[5]. This inhibition operates through direct structural interactions between the CARD and the protease domain and appears to involve allosteric effects on the positioning of the catalytic site loops[53]. The functional consequence of this architecture is that the apoptosome accomplishes caspase-9 activation through not merely one mechanism but rather through multiple complementary means: first, by physically sequestering the inhibitory CARD domain through CARD-CARD interactions, thereby releasing the brake on catalytic activity; and second, by promoting homodimerization of the protease domains when substrate becomes available[5][10][50].

Activation Mechanisms and the Apoptosome Complex

The Apoptosome Platform and Recruitment

The intrinsic apoptotic pathway is initiated when diverse cellular stressors induce mitochondrial outer membrane permeabilization (MOMP), mediated primarily by pro-apoptotic members of the Bcl-2 family such as Bax and Bak, resulting in the release of cytochrome c from the mitochondrial intermembrane space into the cytosol[11][29]. Released cytochrome c binds with high affinity to Apaf-1 and in the presence of deoxyadenosine triphosphate (dATP) or adenosine triphosphate (ATP) stimulates the oligomerization of Apaf-1 into a distinctive heptameric wheel-like platform termed the apoptosome[2][5][10]. The apoptosome functions as a macromolecular scaffolding complex that recruits and activates caspase-9 monomers through multivalent CARD-CARD interactions[10][20]. Recent cryo-electron microscopy (cryo-EM) structures have revealed that a single caspase-9 CARD interacts with multiple Apaf-1 CARDs via asymmetric interfaces with a 4:7 stoichiometry per apoptosome scaffold, indicating that recruitment involves complex multimeric interactions rather than simple 1:1 binding[10][19]. The apoptosome therefore assembles approximately seven copies of caspase-9 monomers on its surface through these CARD-CARD interactions[1].

Dual Mechanisms of Caspase-9 Activation

Two complementary but mechanistically distinct mechanisms contribute to the dramatic activation of caspase-9 upon apoptosome binding[5][10][50]. The first mechanism involves relief of the inhibitory effect of the caspase-9 CARD domain[5]. Structural evidence indicates that assembly of caspase-9 CARD complexes within the apoptosome holoenzyme likely serves to sequester or reorient the inhibitory CARD domain, thereby relieving suppression of the underlying protease domain's catalytic activity[5]. The second activation mechanism proceeds through substrate-dependent dimerization: binding to the apoptosome increases the local concentration of caspase-9 monomers, and when substrate becomes available, the protease domains rapidly and extensively dimerize through a process termed molecular crowding[10][50]. Recent methyl-transverse relaxation optimized spectroscopy (methyl-TROSY) NMR studies have demonstrated that apoptosome-bound caspase-9 protease domains remain monomeric in the absence of substrate but undergo swift homodimerization only upon substrate addition, providing an additional temporal control mechanism that prevents inadvertent activation[10][50]. This substrate-dependent dimerization model reconciles the apparent paradox that while caspase-9 dimerization is essential for catalytic activity, the holoenzyme form exhibits substantially greater activity than simple leucine zipper-induced dimers, because the apoptosome not only facilitates dimerization but also enhances substrate affinity to the physiological substrate procaspase-3[2].

Procaspase-9 Processing and Autocatalytic Cleavage

Upon recruitment to the apoptosome, procaspase-9 undergoes autocatalytic intrachain cleavage at three distinct aspartate residues, primarily after Asp-315 and secondarily after Glu-306 and Asp-330, generating the mature two-chain enzyme composed of the p35 large subunit and p10 small subunit connected by an intersubunit linker[1][7][40]. Remarkably, this autocatalytic processing appears to be essential for full activation, as a caspase-9 triple mutant (E306A/D315A/D330A) that cannot undergo intrachain cleavage fails to achieve proper activation by the apoptosome despite maintaining dimerization capability[40]. The molecular basis for this requirement remains incompletely characterized but likely involves conformational changes necessary for optimal substrate binding or catalytic site positioning. Importantly, the long intersubunit linker connecting p20 and p10 allows caspase-9 to exhibit catalytic activity even in its uncleaved form, distinguishing caspase-9 from most other caspases, which require cleavage for activation[1][7].

Substrate Specificity and Catalytic Mechanism

Cleavage Site Recognition and Substrate Selectivity

Caspase-9, like all caspases, functions as a serine-threonine protease that recognizes specific peptide sequences immediately preceding aspartate residues and cleaves after the aspartate[1][3]. The substrate recognition mechanism involves recognition of four residues N-terminal to the scissile aspartate in positions designated P4, P3, P2, and P1, with the cleavage occurring between P1 (the aspartate) and P1' (the downstream residue)[9][37]. Caspase-9 exhibits a preferred cleavage sequence motif of Leu-Gly-His-Asp (LEHD) in positions P4 through P1, though the full spectrum of recognized sequences demonstrates considerably greater breadth than this consensus motif[4][12][37]. Comprehensive N-terminomics studies employing reverse profiling of substrate libraries have identified that caspase-9 accepts sequences with the motif LESD↓(G/S) for positions P4-P1↓(P1'), exhibiting notable flexibility in position P1' and accepting glycine or serine at this position[37].

A remarkable feature of caspase-9 substrate specificity is its preferential cleavage of the physiological substrate procaspase-3 through intersubunit linker (ISL) cleavage rather than prodomain cleavage[9]. The ISL site within procaspase-3 contains an aspartate at position 175, which caspase-9 cleaves with high efficiency[9]. In contrast, caspase-9 can recognize but cannot efficiently cleave the ISL sites in procaspase-6, even though these sequences superficially resemble recognized caspase-9 cleavage motifs[9]. The P4-P1' sequence of procaspase-6 ISL site 1 (DVVDN) is accessible to the caspase-9 active site yet remains refractory to proteolysis, suggesting that the local three-dimensional context surrounding the cleavage site, beyond simple recognition sequence, critically determines substrate selection[9]. Studies employing substrate variants demonstrate that altering procaspase-6 sites to contain the preferred caspase-9 sequence motif still fails to generate efficient cleavage, indicating that caspase-9 has evolved exquisite selectivity mechanisms ensuring that it preferentially processes downstream effector caspases in a hierarchically controlled manner[9].

Differential Substrate Affinity for Holoenzyme Versus Dimerized Forms

The apoptosome-associated caspase-9 holoenzyme (C9Holo) exhibits dramatically higher substrate affinity for the physiological substrate procaspase-3 compared to leucine zipper-induced caspase-9 dimers (LZ-C9)[2]. While both forms exhibit similar catalytic efficiency (Km and kcat values) for synthetic peptide substrates such as Ac-LEHD-AFC, the caspase-9 holoenzyme demonstrates Km values approximately 30-fold lower for procaspase-3 compared to the leucine zipper dimer[2]. This differential affinity appears to result from the interaction between caspase-9 and the apoptosome scaffold, which enhances substrate recognition and binding rather than merely providing a platform for concentration effects[2]. The dramatic improvement in substrate affinity implies that apoptosome binding generates conformational changes in the caspase-9 protease domain that optimize the substrate-binding pocket, suggesting that recruitment to the apoptosome accomplishes activation through a combination of relieving autoinhibition, promoting favorable dimerization, and enhancing intrinsic substrate recognition[2][5].

The Intrinsic Apoptotic Pathway and Effector Caspase Activation

Procaspase-3 Activation and the Caspase Cascade

Once activated on the apoptosome, caspase-9 executes its primary biological function by proteolytically processing and activating the downstream effector caspases-3 and caspase-7, which then propagate the apoptotic program by cleaving numerous cellular substrates[1][3][6]. The ISL cleavage of procaspase-3 catalyzed by caspase-9 is extraordinarily efficient and represents the canonical initial step in initiating the terminal caspase cascade[2][3]. Activated caspase-3 can then cleave other procaspases including procaspase-6 and additional copies of procaspase-3, as well as hundreds of downstream apoptotic substrates including poly(ADP-ribose) polymerase (PARP), inhibitor of caspase-activated DNase (ICAD), and numerous cytoskeletal and nuclear proteins[12][35]. This hierarchical activation system, in which caspase-9 selectively processes effector caspases despite the broader cleavage specificity of effector caspases themselves, provides regulatory precision ensuring that apoptosis initiation remains firmly under the control of upstream signals[1][3].

Feedback Amplification of Mitochondrial Damage

The caspase cascade initiated by caspase-9 activation establishes a powerful positive feedback loop that amplifies mitochondrial damage[27][30]. Activated caspase-3 cleaves anti-apoptotic Bcl-2 family members including Bcl-2 and Bcl-xL at specific aspartate residues, converting them into pro-apoptotic fragments that promote further Bax and Bak activation[27]. This caspase-dependent cleavage of anti-apoptotic Bcl-2 proteins results in release of Smac/DIABLO from mitochondria, which then neutralizes inhibitor of apoptosis (IAP) proteins and permits additional caspase activation[27]. Additionally, activated caspase-3 can directly promote further cytochrome c release from mitochondria through mechanisms involving the permeability transition pore and inner membrane remodeling[27]. This feedback mechanism ensures robust progression toward apoptosis once the caspase-9 threshold has been crossed and functions as an irreversibility switch, although cells possess protective mechanisms that can suppress this pathway under certain circumstances[1][27].

Requirement for Apoptosome Binding for Sustained Activity

A distinctive feature of caspase-9 that fundamentally differs from other initiator caspases such as caspase-8 is that caspase-9 must maintain binding to the apoptosome to sustain significant catalytic activity[11][23]. In contrast to caspase-8, which becomes released from the death-inducing signaling complex (DISC) upon activation, activated caspase-9 remains sequestered on the apoptosome platform[2][11]. This architectural distinction has profound mechanistic implications: caspase-9 does not function as a soluble protease that diffuses throughout the cytosol but rather operates as a component of a multiprotein complex, fundamentally restricting the spatial domain of its substrate accessibility and providing an additional layer of subcellular compartmentalization to apoptotic signaling[11]. Furthermore, procaspase-9 possesses greater affinity for the apoptosome than activated caspase-9, facilitating continuous recruitment and activation of new caspase-9 molecules while allowing processed p35/p12 caspase-9 to eventually dissociate from the complex[11]. This dynamic cycling creates what has been conceptualized as an apoptosomal molecular timer, in which the intracellular concentration of procaspase-9 determines timer duration, autoprocessing activates the timer, and the dissociation rate of active enzyme dictates the speed at which the timer ticks[11].

Regulation of Caspase-9 Activity Through Phosphorylation

Inhibitory Phosphorylation Sites

Caspase-9 represents one of the most heavily phosphorylated caspases, with numerous kinases converging to regulate its activity through post-translational modification[15][35]. Protein kinase A (PKA) phosphorylates caspase-9 at three sites—serines 99, 183, and 195—all located within the CARD and large subunit regions, resulting in suppression of caspase-9 activation and apoptosis[15][52]. Among these sites, phosphorylation at serine-183 represents the functionally dominant inhibitory site, preventing both procaspase-9 self-processing and substrate binding through a two-stage mechanism[52]. Remarkably, serine-183 phosphorylation in the zymogen form blocks substrate access to the active site, while phosphorylation in the mature form destabilizes the entire caspase-9 core structure, promoting dissociation between the large and small subunits[52]. The mitogen-activated protein kinase (MAPK) kinase ERK phosphorylates caspase-9 at threonine-125, located within the linker connecting the CARD to the catalytic domain, suppressing apoptosis during conditions of growth factor stimulation[15][35]. The protein kinase C isoform zeta (PKCζ) phosphorylates caspase-9 at serine-144, also in the CARD region, inhibiting both caspase-9 activation and the subsequent activation of caspase-3[15]. These inhibitory phosphorylation sites collectively function as molecular OFF switches through which diverse signaling pathways, including those activated during normal growth and proliferation, restrain apoptosis to ensure that only cells experiencing genuine stress undergo programmed death.

Activating Phosphorylation at Tyrosine-153

In contrast to the predominance of inhibitory phosphorylation sites, tyrosine-153 phosphorylation by the c-Abl kinase represents the sole known phosphorylation site that enhances rather than suppresses caspase-9 activity[35][49]. Located within the large subunit of the protease domain, tyrosine-153 forms a hydrogen bond with aspartate-350 in the catalytic site loop in the dimeric, substrate-bound structure, suggesting that phosphorylation at this position could influence catalytic site geometry[49]. However, recent experimental evidence has revealed substantial complexity regarding this site: while early reports suggested that tyrosine-153 phosphorylation promotes caspase-9 self-processing and activation in response to DNA damage, subsequent studies employing phosphomimetic substitutions (Y153E and Y153D) demonstrated that these mutations actually inhibit rather than activate caspase-9[49]. This discrepancy likely arises from distinctions between physiological phosphorylation dynamics and artificial phosphomimetic amino acid substitutions, suggesting that tyrosine-153 may play a complex role in caspase-9 regulation that depends on the broader phosphorylation context and conformational state[49].

Allosteric Inhibition by Akt Kinase

The protein kinase Akt, a central node in growth and survival signaling activated by phosphatidylinositol 3-kinase (PI3K), phosphorylates caspase-9 at serine-196 and functions as an allosteric inhibitor of the protease[4][15][18]. Importantly, the serine-196 phosphorylation site lies far from the active site, yet it suppresses both caspase-9 dimerization and substrate-binding cleft positioning through allosteric mechanisms[4]. This Akt-mediated inhibition represents a critical antiapoptotic pathway by which growth factor signaling actively suppresses the intrinsic apoptotic cascade, ensuring that proliferating cells remain refractory to apoptotic stimuli even if they experience mild stress[4][15]. The therapeutic relevance of this regulatory node is emphasized by the frequent constitutive activation of PI3K/Akt signaling in human cancers, which provides cancer cells with inherent protection against chemotherapy-induced apoptosis[15].

Alternative Splicing and the Caspase-9b Isoform

Regulation of Caspase-9a/9b Splicing Ratios

The CASP9 gene generates two functionally antagonistic isoforms through alternative splicing: the pro-apoptotic caspase-9a that retains exons 3, 4, 5, and 6, and the anti-apoptotic caspase-9b that excludes these exons[4][21][24]. This alternatively spliced cassette encodes amino acids 140-289, which comprise the central region of the large subunit catalytic domain[4]. As a result, caspase-9b lacks the core catalytic domain and functions as a dominant-negative inhibitor of caspase-9a by competing for binding to the apoptosome and preventing the caspase enzyme cascade[4][21][31]. The ratio of caspase-9a/9b expression critically determines the apoptotic competence of cells; a low caspase-9a/9b ratio correlates with an anti-apoptotic phenotype and tumor promotion, particularly in non-small cell lung carcinomas (NSCLC)[21][24].

The alternative splicing of CASP9 is dysregulated in human cancers and is controlled by oncogenic signaling pathways[21][24]. Phosphoinositide 3-kinase (PI3K) and Akt signaling dramatically decrease the caspase-9a/9b ratio by promoting exclusion of the exon 3-6 cassette through phosphorylation-dependent mechanisms[21]. Specifically, Akt phosphorylates the serine-arginine protein kinase (SR) splicing factor SRp30a at serines 199, 201, 227, and 234, resulting in altered recognition of the caspase-9 splice sites and preferential inclusion of exon 7, which introduces a premature stop codon characteristic of the caspase-9b isoform[21]. Remarkably, epidermal growth factor receptor (EGFR) mutations and overexpression dramatically promote caspase-9b expression through this PI3K/Akt/SRp30a axis, providing cancer cells with a mechanism to suppress intrinsic apoptosis during tyrosine kinase-driven oncogenic transformation[21]. This splicing-based mechanism of apoptosis evasion represents a sophisticated adaptation by which oncogenic signaling pathways accomplish apoptosis suppression not merely through phosphorylation of existing caspase-9 protein but through dynamic alteration of which caspase-9 isoforms are synthesized, thereby providing more stable and heritable apoptosis resistance[21][24].

Localization and Subcellular Compartmentalization

Cytosolic Localization and Apoptosome Assembly

In non-stressed cells, caspase-9 predominantly localizes to the cytosol as an inactive monomer lacking typical mitochondrial targeting sequences[11][32]. Upon induction of apoptosis through intrinsic pathway stimuli, caspase-9 is recruited to the apoptosome, which forms at sites of cytochrome c release, thereby concentrating large amounts of caspase-9 in proximity to its substrate and preventing inappropriate activation in the cytosol[32]. This spatial compartmentalization of caspase-9 within the apoptosome complex provides an elegant mechanism for ensuring that caspase-9 activation remains tightly restricted to cells experiencing genuine mitochondrial stress[11][32]. The long disordered linker regions connecting the CARD to the protease domain allow significant flexibility of the protease domain when tethered to the apoptosome, permitting the protease domains to sample different conformational states and facilitating the substrate-dependent homodimerization essential for catalytic activation[10][50].

Mitochondrial Translocation During Apoptosis

While caspase-9 lacks a classical mitochondrial targeting sequence and is primarily cytosolic, evidence indicates that a proportion of caspase-9 translocates to mitochondria during the apoptotic process[26][32]. Biochemical studies employing mitochondrial fractionation demonstrate that caspase-9 migrates into mitochondria after the latter undergo membrane permeability transition characteristic of apoptotic cells, suggesting that caspase-9 translocation follows rather than precedes mitochondrial permeabilization[26][32]. The physiological significance of mitochondrial caspase-9 localization remains incompletely understood but may involve amplification of mitochondrial damage through direct caspase-mediated effects on mitochondrial proteins or through generation of reactive oxygen species (ROS) that further promote mitochondrial dysfunction[26][47].

Non-Apoptotic Functions of Caspase-9

Autophagy Regulation and Mitochondrial Homeostasis

Beyond its canonical role in triggering apoptosis, caspase-9 executes a sophisticated non-apoptotic function in the positive regulation of macroautophagy through mechanisms involving the maintenance of mitochondrial homeostasis[44][57][60]. During nutrient starvation or growth factor deprivation, caspase-9 undergoes activation without activating the downstream effector caspase-3, suggesting compartmentalized and selective caspase cascade activation in autophagic contexts[44][60]. Genetic ablation of CASP9 or pharmacological inhibition of caspase-9 activity impairs autophagy flux despite normal initiation of autophagy, instead resulting in accumulated autophagosomes with prolonged lifetimes and defective maturation[44][57]. Mechanistically, caspase-9 knockout cells accumulate inactive ATG3, exhibiting decreased lipidation of Atg8-family members including MAP1LC3B and GABARAPL1, resulting in impaired autophagosome membrane sealing and maturation[44][57]. These autophagic defects correlate with altered mitochondrial morphology, depolarization of mitochondrial membrane potential, and reduced production of mitochondrial reactive oxygen species[44][57]. Remarkably, while exogenous hydrogen peroxide can partially restore Atg8-family lipidation in CASP9 knockout cells, only caspase-9 expression itself fully restores both mitochondrial ROS production and mitochondrial morphology, indicating that caspase-9 regulates mitochondrial homeostasis through mechanisms beyond simple ROS generation[44][57]. This non-apoptotic function positions caspase-9 as a critical regulator of cellular catabolism and energy metabolism through its influence on mitochondrial function, thereby connecting apoptotic and catabolic cellular programs through a shared molecular mediator[44][60].

Innate Immune Sensing and Interferon Production

Intriguingly, caspase-9 has emerged as a critical negative regulator of innate immune sensing through mechanisms involving suppression of type I interferon responses[39][42]. When mitochondrial outer membrane permeabilization occurs via Bax and Bak activation in the absence of active caspase-9, the released mitochondrial DNA (mtDNA) activates the cytosolic nucleotidyl transferase cyclic GMP-AMP synthase (cGAS), generating the second messenger cyclic GMP-AMP dinucleotide (cGAMP) and activating the stimulator of interferon genes (STING) protein[39][42]. This cGAS-STING signaling cascade activates interferon regulatory factor 3 (IRF3) and results in robust production of type I interferon and interferon-stimulated genes, establishing a potent antiviral state[39][42]. However, when caspase-9 is activated following MOMP, the protease degrades or inactivates components of the cGAS-STING pathway, suppressing type I interferon production and maintaining the immunological silence characteristic of apoptotic cell death[39][42]. Caspase-9-deficient cells or cells treated with caspase inhibitors exhibit constitutive activation of the mtDNA/cGAS/STING/IRF3 axis and produce abundant type I interferon even during apoptotic conditions[39][42]. This immunoregulatory function explains why tumor cells can exploit caspase-9 activation to suppress the immunogenic aspects of chemotherapy-induced cell death, and conversely, why caspase-9 inhibition can convert immunologically silent apoptosis into immunogenic cell death capable of generating anti-tumor immunity[33][39]. Recent studies demonstrate that dual inhibition of caspase-9 combined with heat shock protein 90 (Hsp90) inhibitors or chemotherapy robustly activates innate immune sensing in tumor cells while maintaining cell death, thereby converting standard apoptotic therapies into immunogenic cell death modalities[33].

Endothelial Dysfunction and Neurovascular Injury

Recent discoveries have identified non-apoptotic endothelial caspase-9 signaling as a critical mediator of ischemic injury in hypoxia-ischemia models[43][46]. In a mouse model of retinal vein occlusion (RVO), pharmacological inhibition or genetic deletion of caspase-9 specifically from endothelial cells significantly reduces vascular edema, restores vascular integrity, and provides robust neuroprotection, with caspase-9 inhibition providing stronger neuronal and vascular protection than VEGF neutralization[43][46]. Remarkably, endothelial caspase-9 activation following hypoxia-ischemia appears to occur independently of apoptosis, as caspase-7 is activated downstream of caspase-9 even in endothelial cells that remain viable[43]. The endothelial caspase-9 activation following ischemic injury promotes vascular barrier dysfunction through mechanisms that remain to be fully elucidated but likely involve caspase-mediated modifications of endothelial tight junction proteins, adhesion molecules, and cytoskeletal components[43]. This non-apoptotic endothelial caspase-9 function demonstrates that caspase-9 can operate as a multifunctional integrator of hypoxic stress in vascular tissues, linking mitochondrial stress to vascular dysfunction through mechanisms distinct from apoptosis[43][46].

Synaptic Plasticity and Memory Functions

Non-apoptotic caspase-9 signaling in neurons contributes to memory formation and synaptic plasticity through mechanisms that appear to be independent of the apoptotic cascade[56]. In a mouse model of familial Danish dementia (FDD) caused by mutations in the BRI2/ITM2B gene, selective inhibition of caspase-9 activity with a highly specific caspase-9 inhibitor rescues both defects in long-term potentiation (LTP) and memory acquisition without affecting normal synaptic plasticity in control mice[56]. Activated caspase-9 is detected in hippocampal synaptic fractions of FDD mice, suggesting compartmentalized caspase-9 activation in the synaptic compartment distinct from somatic caspase activation[56]. These findings indicate that physiological caspase-9 signaling contributes to regulated synaptic remodeling and memory processing, and that aberrant caspase-9 activation in synaptic compartments contributes to neurodegenerative pathology[56]. The molecular substrates and downstream effectors through which synaptic caspase-9 influences plasticity remain incompletely characterized but may involve modified processing of synaptic proteins, local alterations in mitochondrial function, or caspase-mediated effects on synaptic structure[56].

Regulation of Necroptosis

Caspase-9 participates in the intersection between apoptotic and necroptotic pathways, with evidence indicating that caspase-9 can regulate whether cells undergo apoptosis or necroptosis depending on the broader context of kinase activation[36][45]. During death receptor signaling when caspase-8 is inhibited, receptor-interacting serine/threonine-protein kinases RIPK1 and RIPK3 form the necrosome and activate mixed lineage kinase domain-like protein (MLKL) to trigger necroptosis[17][36]. Recent evidence suggests that caspase-9 can interact with RIPK3 and influence necroptotic pathway activation, and in models of pancreatic necroptosis, knockout of caspase-9 from pancreatic acinar cells results in decreased severity of cerulein-induced acute pancreatitis, suggesting that caspase-9 promotes necroptotic injury[36]. This crosstalk between caspase-9 and necroptotic machinery indicates that caspase-9 functions as a decision node integrating signals that determine cellular fate between apoptosis, autophagy, necroptosis, and survival[36][45].

Developmental Roles and Central Nervous System Formation

Caspase-9 in Embryonic Development and CNS Formation

During embryonic development, particularly in central nervous system (CNS) formation, caspase-9 executes essential functions in sculpting neural populations through precisely timed and spatially restricted apoptosis[35][55][59]. Genetic knockout studies demonstrate that mice lacking caspase-9 die perinatally with severe brain abnormalities including exencephaly, ventricular obstructions, and protrusion formations, similar to phenotypes observed in caspase-3 knockout mice, indicating that caspase-9-mediated apoptosis is essential for normal brain development[35][59]. During lens fiber cell differentiation, caspase-9 is expressed and activated in spatially restricted domains of differentiating lens epithelium coinciding with the period of fiber cell denucleation, and inhibition of caspase-9 activity suppresses nuclear degeneration[32][55]. These developmental studies establish caspase-9 as a critical executioner of apoptosis during developmental morphogenesis and tissue patterning[35][59].

Non-Apoptotic Neurodevelopmental Functions

Beyond its roles in developmental apoptosis, caspase-9 participates in non-apoptotic neurodevelopmental processes including axon guidance, synapse formation, and synaptic pruning[35][59]. Caspases in general, and caspase-9 specifically, modulate the positioning and function of growth cone cytoskeletal elements, potentially through direct proteolysis of cytoskeletal proteins or through effects on mitochondrial positioning within developing neurites[35][59]. The molecular distinction between conditions in which caspase-9 activation leads to apoptotic death versus differentiation-promoting functions remains incompletely understood but likely involves the subcellular compartmentalization of caspase-9 signaling, the duration and magnitude of protease activation, and the availability of distinct substrate pools in different cellular compartments[35][59].

Caspase-9 in Cancer Biology and Therapeutic Applications

Caspase-9 Dysregulation in Cancer

Dysregulation of caspase-9 expression, activity, or function represents a fundamental mechanism of apoptosis evasion in human malignancies[1][36][51]. A subset of tumors suppress caspase-9 expression or activity as an apoptosis-evasion strategy, with evidence indicating that caspase-9 suppression increases chemoresistance to multiple drug classes[1][51]. Conversely, other tumors express elevated levels of the anti-apoptotic caspase-9b isoform, which prevents apoptosis-induced caspase-3 activation[1][36]. Mutations or polymorphisms within the CASP9 gene have been associated with various cancers, neurological disorders, autoimmune pathologies, and other degenerative diseases[36]. The correlation between altered caspase-9 function and cancer susceptibility suggests that caspase-9 acts as a critical tumor suppressor whose loss promotes malignant transformation, and conversely, that restoring caspase-9 function represents a rational therapeutic strategy for cancer treatment[36][51].

Chemotherapy-Induced Apoptosis and Caspase-9 Dependency

The sensitivity of cancer cells to chemotherapy and ionizing radiation critically depends on caspase-9-mediated intrinsic apoptosis pathway activation[1][8][16]. DNA-damaging agents induce p53 stabilization, leading to transcriptional activation of pro-apoptotic genes including those encoding Bcl-2 family members and other apoptosis regulators[1][8]. This p53-dependent transcriptional response triggers mitochondrial damage and cytochrome c release, subsequently activating caspase-9 on the apoptosome[1][8][16]. Caspase-9-deficient cancer cells exhibit profound chemoresistance to diverse drug classes including platinum compounds, topoisomerase inhibitors, and antimetabolites[1][8]. Studies examining the requirement for caspase-9 in drug-induced apoptosis demonstrate that reconstitution of caspase-9 expression in caspase-9-deficient cells restores both mitochondrial membrane potential loss and caspase-3 activation following chemotherapy exposure, providing genetic evidence that caspase-9 is essential for drug-induced apoptosis in cancer cells[8].

Inducible Caspase-9 as a Safety Switch for Cell Therapy

The capacity to rationally control caspase-9 activation through chemical inducers of dimerization (CID) has been harnessed for development of "suicide gene" systems designed to provide safety switches for cellular therapies[1][4][7]. The inducible caspase-9 (iCasp9) system, also termed the CaspaCIDe system, consists of a fusion protein combining a drug-binding domain (FK506-F36V) with a truncated caspase-9 lacking its physiological CARD domain[1][7]. The chemical inducers AP1903 or AP20187 bind to iCasp9 and induce homodimerization of the caspase-9 truncated domain, leading to activation of the downstream caspase cascade and rapid apoptosis[1][7]. Administration of 10 nanomolar doses of CID can provoke apoptosis in greater than 99% of cells expressing iCasp9 within one hour[1]. The iCasp9 system exhibits marked advantages compared to alternative suicide genes including the herpes simplex virus thymidine kinase (HSV-TK) system, including lower potential immunogenicity, lower baseline activity independent of the dimerizer, and high sensitivity to dimerizer-induced apoptotic death[1][7]. The Rivo-cel technology based on inducible caspase-9 has entered clinical trials for improving hematopoietic stem cell transplantation outcomes by conferring prophylaxis against graft-versus-host disease through inducible elimination of donor T cells expressing iCasp9[36].

Caspase-9 Inhibition as an Immunotherapy Strategy

Recent therapeutic innovations have identified caspase-9 inhibition as a strategy to enhance immunogenicity of chemotherapy-induced cell death[33][36]. Blockade of caspase-9 signaling in tumor cells exposed to Hsp90 inhibitors or chemotherapy robustly activates the mtDNA/cGAS/STING innate immune sensing pathway, leading to production of type I interferon and other immunogenic damage-associated molecular patterns[33][39]. This caspase-9 inhibition-enhanced innate immune activation results in recruitment of CD8+ T cells and establishment of adaptive anti-tumor immunity capable of controlling tumor growth even after treatment cessation[33]. Importantly, combining caspase-9 inhibition with subsequent PD-L1 checkpoint blockade achieves complete tumor regression in experimental models, suggesting that dual targeting of caspase-9 signaling combined with immune checkpoint inhibitors may overcome adaptive resistance mechanisms in cancer immunotherapy[33].

Recent Research Developments and Emerging Concepts

Structural and Mechanistic Advances

Recent cryo-EM structural determination of the Apaf-1 apoptosome bound to caspase-9 has provided unprecedented atomic-level detail regarding the architecture of the activation complex[5][10]. These structures reveal that caspase-9 CARD domains interact with multiple Apaf-1 CARDs through asymmetric interfaces, and that the protease domains remain flexibly tethered to the apoptosome through long disordered linkers, allowing dynamic conformational sampling[5][10]. Combined with NMR spectroscopy studies employing methyl-TROSY approaches, these structural advances have established that substrate-dependent dimerization driven by molecular crowding on the apoptosome platform represents the primary mechanism of caspase-9 activation, with CARD sequestration providing an additional secondary activation mechanism[10][50]. These mechanistic insights have profound implications for therapeutic targeting of caspase-9, suggesting that stabilizing or destabilizing specific conformational states might provide approaches to modulate caspase-9 activity[10][50].

Comprehensive Substrate Profiling

Modern proteomic approaches employing N-terminomics have enabled comprehensive identification of caspase-9 substrates at the proteome-wide level[12][37]. These studies have identified 124 caspase-9 substrate proteins, with 57% of all caspase-9 substrates also cleaved by caspase-3, indicating substantial functional redundancy between these proteases with evolutionarily conserved substrate preferences[12][37]. Notably, reverse N-terminomics approaches have revealed hundreds of previously unknown caspase-9 cleavage sites and substrates not detected in traditional forward approaches, expanding appreciation of caspase-9's proteolytic range and revealing potential novel mechanisms through which caspase-9 influences diverse cellular pathways[12][37]. This proteome-wide substrate knowledge provides a foundation for understanding how caspase-9 coordinates the execution of apoptosis and non-apoptotic programs[12][37].

Caspase-9 Polymorphisms and Disease Association

Genome-wide association studies and candidate gene analyses have identified multiple CASP9 polymorphisms associated with increased susceptibility to various diseases including neurological disorders, autoimmune conditions, and lumbar disc disease[36]. These polymorphisms may alter caspase-9 expression levels, splicing patterns, or functional activities, thereby influencing disease predisposition[36]. The association of CASP9 variants with neurodegeneration, retinal neuropathy, myasthenic syndromes, cardiomyopathies, atherosclerosis, and autoimmune disease suggests that dysregulation of caspase-9 activity or expression contributes to pathogenesis of numerous chronic diseases beyond cancer[36]. Future studies examining the functional consequences of CASP9 polymorphisms and their interactions with environmental and genetic modifiers may illuminate mechanisms of disease susceptibility[36].

Conclusion

Caspase-9, encoded by the human CASP9 gene (UniProt: P55211), has emerged as one of the most multifunctional and extensively characterized proteases in human biology. As the initiator caspase of the intrinsic mitochondrial apoptotic pathway, caspase-9 responds to diverse cellular stressors including DNA damage, growth factor withdrawal, hypoxia, and oxidative stress by recruiting and activating downstream effector caspases that execute the morphological and biochemical changes constituting apoptosis[1][7]. The remarkable specificity with which caspase-9 accomplishes this function reflects sophisticated mechanisms of activation including CARD domain sequestration on the apoptosome platform, substrate-dependent protease domain homodimerization, and selective cleavage of physiological substrates including procaspase-3[2][5][10].

The regulation of caspase-9 activity integrates signals from multiple signaling pathways through mechanisms including reversible phosphorylation by pro-survival kinases such as Akt, MAPK, and PKA, and through alternative splicing controlled by oncogenic pathways[15][21][52]. The spatial organization of caspase-9 within the apoptosome complex and the requirement for apoptosome binding to sustain activity provide subcellular compartmentalization of the apoptotic program, ensuring that caspase-9 activation remains tightly restricted to cells experiencing genuine mitochondrial stress[11][23][32].

Beyond its classical role in apoptosis, caspase-9 executes increasingly appreciated non-apoptotic functions in autophagy regulation and mitochondrial homeostasis, innate immune sensing and interferon production, endothelial vascular barrier function, and synaptic plasticity and memory formation[36][39][43][44][56][57]. These non-apoptotic roles position caspase-9 as a multifunctional integrator of cellular stress responses, connecting apoptotic, catabolic, immunological, and synaptic processes through a shared molecular mediator[36][43][44].

In cancer biology, dysregulation of caspase-9 through altered expression, splicing, or post-translational modification represents a fundamental mechanism of apoptosis evasion and contributes to chemoresistance[1][36][51]. Conversely, pharmacological or genetic modulation of caspase-9 has emerged as a rational therapeutic strategy, with inducible caspase-9 systems providing clinically viable safety switches for cell therapy, and caspase-9 inhibition enhancing immunogenicity of chemotherapy through activation of innate immune sensing pathways[33][36]. The remarkable progress in understanding caspase-9 structure, mechanisms, regulation, and multifaceted biological roles positions this protease as a critical target for therapeutic intervention in cancer, neurodegeneration, and inflammatory diseases. Future research elucidating the specific mechanisms determining whether caspase-9 activation results in apoptosis, autophagy, necroptosis, or other cellular outcomes promises to reveal fundamental principles governing cellular fate determination and may enable more precise and effective therapeutic targeting of caspase-9 in diverse disease contexts.

Citations

https://pmc.ncbi.nlm.nih.gov/articles/PMC5410359/
https://pmc.ncbi.nlm.nih.gov/articles/PMC2904439/
https://pubchem.ncbi.nlm.nih.gov/protein/P55211
https://en.wikipedia.org/wiki/Caspase-9
https://www.pnas.org/doi/10.1073/pnas.1620626114
https://www.thermofisher.com/proteins/product/Human-Caspase-9-Synthetic-Peptide/PEP-0030
https://www.molbiolcell.org/doi/10.1091/mbc.e06-04-0263
https://pmc.ncbi.nlm.nih.gov/articles/PMC8489496/
https://www.pnas.org/doi/10.1073/pnas.2310944120
https://pmc.ncbi.nlm.nih.gov/articles/PMC3717204/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9116730/
https://pmc.ncbi.nlm.nih.gov/articles/PMC8257737/
https://elifesciences.org/articles/101114
https://pmc.ncbi.nlm.nih.gov/articles/PMC1291226/
https://aacrjournals.org/mct/article/1/9/679/233921/p53-Mediates-DNA-Damaging-Drug-induced-Apoptosis
https://pmc.ncbi.nlm.nih.gov/articles/PMC8684821/
https://reactome.org/content/detail/R-HSA-198621
https://pmc.ncbi.nlm.nih.gov/articles/PMC10743466/
https://pmc.ncbi.nlm.nih.gov/articles/PMC6365033/
https://pubmed.ncbi.nlm.nih.gov/21045158/
https://journals.biologists.com/jcs/article/123/19/3209/31331/Regulation-of-the-Apaf-1-caspase-9-apoptosome
https://genesdev.cshlp.org/content/13/24/3179.full.html
https://aacrjournals.org/cancerres/article/70/22/9185/561001/Alternative-Splicing-of-Caspase-9-Is-Modulated-by
https://pubmed.ncbi.nlm.nih.gov/27865841/
https://pmc.ncbi.nlm.nih.gov/articles/PMC2192979/
https://pubmed.ncbi.nlm.nih.gov/23539542/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7001279/
https://www.longdom.org/open-access/promotion-of-caspase-activation-by-caspase9mediated-feedback-amplification-of-mitochondrial-damage-48294.html
https://pmc.ncbi.nlm.nih.gov/articles/PMC1570907/
https://pubmed.ncbi.nlm.nih.gov/38056894/
https://portlandpress.com/biochemj/article/384/2/201/78598/The-protein-structures-that-shape-caspase-activity
https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.702404/full
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.701301/full
https://pmc.ncbi.nlm.nih.gov/articles/PMC4569095/
https://pmc.ncbi.nlm.nih.gov/articles/PMC4272443/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3663534/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7117139/
https://academic.oup.com/proteincell/article/7/1/11/6794440
https://pmc.ncbi.nlm.nih.gov/articles/PMC7311551/
https://www.tandfonline.com/doi/full/10.1080/15548627.2019.1695398
https://pmc.ncbi.nlm.nih.gov/articles/PMC6495317/
https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1209527/full
https://pmc.ncbi.nlm.nih.gov/articles/PMC1196205/
https://elearning.uniroma1.it/pluginfile.php/972753/mod_folder/content/0/CLMF%209%20apoptosis%20and%20necrosis.pdf?forcedownload=1
https://pmc.ncbi.nlm.nih.gov/articles/PMC5766954/
https://www.ncbi.nlm.nih.gov/books/NBK6027/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5988757/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5878146/
https://ashpublications.org/blood/article/98/9/2603/53464/Cellular-stress-response-and-apoptosis-in-cancer
https://pmc.ncbi.nlm.nih.gov/articles/PMC3543220/
https://www.molbiolcell.org/doi/abs/10.1091/mbc.e09-12-1031
https://pubmed.ncbi.nlm.nih.gov/31818185/

Notes

(CASP9-notes.md)

CASP9 (Caspase-9) Notes - ISOFORMS Project

Key Isoform Biology

CASP9 is an initiator caspase in the intrinsic apoptosis pathway, but has a dominant-negative short isoform.

Isoforms (4 named)

Isoform	UniProt ID	Synonym	Key Feature	Function
Isoform 1	P55211-1	9L, Alpha	Full-length, catalytically active	INDUCES APOPTOSIS
Isoform 2	P55211-2	9S, Beta	Lacks catalytic domain	DOMINANT-NEGATIVE INHIBITOR
Isoform 3	P55211-3	Gamma	-	Unknown
Isoform 4	P55211-4	-	-	Unknown

Critical Antagonism: Long vs Short

Caspase-9L (Isoform 1):
- Contains CARD domain for Apaf-1 binding
- Contains catalytic domain
- Forms apoptosome with Apaf-1 and cytochrome c
- Cleaves and activates CASP3/CASP7
- PRO-APOPTOTIC

Caspase-9S (Isoform 2):
UniProt explicitly states:

"Lacks activity is an dominant-negative inhibitor of caspase-9" PMID:10070954

Mechanism: Caspase-9S competes with Caspase-9L for Apaf-1 binding but cannot activate downstream caspases.

Mechanism of Antagonism

Apaf-1 + Cyt c + dATP → Apoptosome

If Caspase-9L binds: → Apoptosis
If Caspase-9S binds: → No apoptosis (dominant-negative)

The ratio of 9L/9S determines apoptotic sensitivity.

GOA Annotation Status

109 total annotations
NO isoform-specific annotations (no P55211-X identifiers)
Annotations conflate pro-apoptotic 9L with anti-apoptotic 9S

Expected Annotation Issues

"Caspase activity" - TRUE for isoform 1, FALSE for isoform 2
"Positive regulation of apoptotic process" - TRUE for isoform 1, FALSE for isoform 2
"Negative regulation of apoptotic process" - should be annotated for isoform 2!
"Apoptosome" annotations - both isoforms can be in apoptosome, but with opposite effects

Biological Significance

Like BCL2L1, this is a case where the balance between isoforms determines cell fate:
- High 9L/9S ratio → apoptosis-sensitive
- Low 9L/9S ratio → apoptosis-resistant

Cancer cells often shift this ratio towards 9S to evade apoptosis.

Key References

PMID:10070954 - Caspase-9S dominant-negative function

📄 View Raw YAML

id: P55211
gene_symbol: CASP9
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: 'CASP9 (Caspase-9) is the initiator caspase of the intrinsic apoptosis
  pathway. CRITICAL ISOFORM BIOLOGY: Alternative splicing produces 4 isoforms with
  ANTAGONISTIC functions: (1) Caspase-9L (isoform 1, P55211-1, Alpha) is the full-length
  ACTIVE enzyme that binds Apaf-1 in the apoptosome and cleaves effector caspases
  to INDUCE APOPTOSIS; (2) Caspase-9S (isoform 2, P55211-2, Beta) lacks the catalytic
  domain and acts as a DOMINANT-NEGATIVE INHIBITOR that competes with 9L for Apaf-1
  binding [PMID:10070954]. UniProt states "Isoform 2: Lacks activity is an dominant-negative
  inhibitor of caspase-9". All current GOA apoptosis annotations refer to the pro-apoptotic
  function - MISSING the anti-apoptotic isoform 2 function.'
existing_annotations:
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Caspase-9 is predominantly localized in the cytoplasm as an 
      inactive monomer in non-stressed cells [PMID:12782307, deep research]. The
      IBA annotation from phylogenetic inference is well-supported. Both 
      isoforms would be cytoplasmic as neither has specific targeting signals.
    action: ACCEPT
    reason: Cytoplasmic localization is well-established for procaspase-9. The 
      deep research confirms "In non-stressed cells, caspase-9 predominantly 
      localizes to the cytosol as an inactive monomer lacking typical 
      mitochondrial targeting sequences." This applies to both isoforms as the 
      CARD domain (retained in both) does not contain targeting signals.
    supported_by:
    - reference_id: PMID:12782307
      supporting_text: caspase-9 is in the cytoplasm of non-apoptotic pituitary 
        cells
    - reference_id: file:human/CASP9/CASP9-deep-research-perplexity.md
      supporting_text: 'provider: perplexity'
- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Caspase-9 is central to the intrinsic apoptotic pathway. The IBA 
      annotation correctly identifies involvement in apoptosis, which is the 
      canonical function of isoform 1. However, isoform 2 (Caspase-9S) INHIBITS 
      apoptosis as a dominant-negative.
    action: ACCEPT
    reason: The GO term "apoptotic process" is a broad BP term that applies to 
      proteins involved in apoptosis regardless of whether they promote or 
      inhibit it. The term definition includes regulation. Isoform 1 induces 
      apoptosis while isoform 2 inhibits it - both are involved in the apoptotic
      process. The IBA inference from phylogenetic conservation is sound for the
      canonical pro-apoptotic function.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: Activated caspase-9 in turn cleaves and activates 
        caspase-3
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'Cysteine-type endopeptidase activity is the core enzymatic function
      of caspase-9 (isoform 1). CRITICAL: Isoform 2 (Caspase-9S) LACKS this activity
      as it is missing the catalytic domain (residues 140-289). UniProt explicitly
      states "Isoform 2: Lacks activity".'
    action: ACCEPT
    reason: This annotation is correct for the canonical isoform 1 (P55211-1). 
      The IBA phylogenetic inference is valid because the catalytic activity is 
      the defining feature of caspase-9 orthologs. The catalytic dyad (Cys-287 
      and His-237) is conserved across the family. Note that isoform 2 would NOT
      have this activity.
    supported_by:
    - reference_id: PMID:16916640
      supporting_text: Our study demonstrates the efficiency by which the 
        executioner caspases are activated in vivo
    - reference_id: PMID:9390557
      supporting_text: Activated caspase-9 in turn cleaves and activates 
        caspase-3
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Cytosolic localization is well-established for procaspase-9 in 
      non-apoptotic cells. The apoptosome forms in the cytosol upon cytochrome c
      release from mitochondria.
    action: ACCEPT
    reason: 'Deep research confirms cytosolic localization: "In non-stressed cells,
      caspase-9 predominantly localizes to the cytosol as an inactive monomer." Multiple
      experimental studies confirm this. The IBA annotation is phylogenetically sound.'
    supported_by:
    - reference_id: PMID:12782307
      supporting_text: caspase-9 is in the cytoplasm of non-apoptotic pituitary 
        cells
- term:
    id: GO:0043525
    label: positive regulation of neuron apoptotic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'Caspase-9 plays a documented role in neuronal apoptosis during development
      and in neurodegenerative conditions. Caspase-9 knockout mice show severe brain
      abnormalities due to reduced developmental neuronal apoptosis. CRITICAL: This
      applies to isoform 1 only.'
    action: ACCEPT
    reason: 'Deep research states: "mice lacking caspase-9 die perinatally with severe
      brain abnormalities including exencephaly, ventricular obstructions, and protrusion
      formations." This demonstrates caspase-9''s role in neuronal apoptotic processes
      during CNS development. IBA inference from phylogenetic conservation is appropriate
      for this well-characterized function of isoform 1.'
    supported_by:
    - reference_id: deep-research
      supporting_text: mice lacking caspase-9 die perinatally with severe brain 
        abnormalities including exencephaly, ventricular obstructions, and 
        protrusion formations
- term:
    id: GO:0008630
    label: intrinsic apoptotic signaling pathway in response to DNA damage
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'Caspase-9 is the initiator caspase of the intrinsic apoptotic pathway
      activated by DNA damage. c-Abl phosphorylates caspase-9 at Tyr-153 in response
      to DNA damage, promoting apoptosis. CRITICAL: This pro-apoptotic function is
      isoform 1 specific.'
    action: ACCEPT
    reason: DNA damage triggers the intrinsic pathway through p53-mediated 
      transcription of pro-apoptotic Bcl-2 family members, leading to MOMP, 
      cytochrome c release, and caspase-9 activation. PMID:15657060 demonstrates
      c-Abl directly phosphorylates caspase-9 in DNA damage response. IBA 
      phylogenetic inference is sound for this core function.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: c-Abl phosphorylates caspase-9 on Tyr-153 in vitro and in
        cells treated with DNA damaging agents
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation of cysteine-type endopeptidase activity is redundant
      with IBA annotation. Correct for isoform 1, but isoform 2 lacks the 
      catalytic domain.
    action: ACCEPT
    reason: This is a broader IEA annotation that is consistent with the IBA 
      annotation. While less specific than IBA, it is not incorrect. The 
      catalytic activity is confirmed by multiple experimental studies.
    supported_by:
    - reference_id: PMID:16916640
      supporting_text: Caspase-7 is an obligate dimer of catalytic domains, with
        generation of activity requiring limited proteolysis within a region 
        that separates the large and small chains of each domain
- term:
    id: GO:0006508
    label: proteolysis
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Proteolysis is a parent term of cysteine-type endopeptidase 
      activity. This is a very general annotation but not incorrect for isoform 
      1.
    action: ACCEPT
    reason: Caspase-9 is definitively a protease that cleaves substrates. The 
      term is appropriately general for an IEA annotation. More specific terms 
      are available via IBA and IDA annotations.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: Activated caspase-9 in turn cleaves and activates 
        caspase-3
- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation of apoptotic process is redundant with IBA 
      annotation. Correct as caspase-9 is a key player in apoptosis, with 
      isoform 1 promoting and isoform 2 inhibiting the process.
    action: ACCEPT
    reason: Consistent with other evidence. The IEA provides computational 
      support for the experimentally validated apoptotic function.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: caspase-9 is the most upstream member of the apoptotic 
        protease cascade that is triggered by cytochrome c and dATP
- term:
    id: GO:0006974
    label: DNA damage response
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: Caspase-9 participates in DNA damage response primarily through its
      role as the executor of DNA damage-induced apoptosis. c-Abl phosphorylates
      caspase-9 in response to DNA damage.
    action: ACCEPT
    reason: The deep research and PMID:15657060 confirm caspase-9's role in DNA 
      damage response. The ARBA machine learning annotation correctly captures 
      this function.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: The c-Abl tyrosine kinase is also involved in the 
        apoptotic response to DNA damage
- term:
    id: GO:0008233
    label: peptidase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Peptidase activity is a parent term of cysteine-type endopeptidase 
      activity. Very general but correct for isoform 1.
    action: ACCEPT
    reason: This is a very general parent term. More specific annotations are 
      available. Correct for the canonical catalytically active isoform.
    supported_by:
    - reference_id: PMID:16916640
      supporting_text: Caspase-7 is an obligate dimer of catalytic domains, with
        generation of activity requiring limited proteolysis within a region 
        that separates the large and small chains of each domain
- term:
    id: GO:0008234
    label: cysteine-type peptidase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Cysteine-type peptidase activity is a parent term of the more 
      specific cysteine-type endopeptidase activity annotation. Correct for 
      isoform 1.
    action: ACCEPT
    reason: Parent term of the more specific annotation. Consistent with 
      caspase-9's function as a cysteine protease using the catalytic dyad of 
      Cys-287 and His-237.
    supported_by:
    - reference_id: PMID:16916640
      supporting_text: Caspase-7 is an obligate dimer of catalytic domains, with
        generation of activity requiring limited proteolysis within a region 
        that separates the large and small chains of each domain
- term:
    id: GO:0009411
    label: response to UV
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: UV irradiation causes DNA damage that can trigger 
      caspase-9-mediated apoptosis via the intrinsic pathway.
    action: ACCEPT
    reason: PMID:15657060 demonstrates that DNA damaging agents including UV 
      activate caspase-9 through c-Abl-mediated phosphorylation. The annotation 
      captures the role of caspase-9 in UV-induced apoptosis.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: Caspase-9(Y153F) also attenuated DNA damage-induced 
        processing of caspase-9 to p35, activation of caspase-3, and apoptosis
- term:
    id: GO:0016787
    label: hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Hydrolase activity is a very general parent term. Caspases 
      hydrolyze peptide bonds. Correct but uninformative for isoform 1.
    action: ACCEPT
    reason: Very general but correct parent term. The UniProtKB keyword mapping 
      correctly identifies caspase-9 as a hydrolase. More specific terms provide
      better annotation.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: Activated caspase-9 in turn cleaves and activates 
        caspase-3
- term:
    id: GO:0042981
    label: regulation of apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Caspase-9 regulates apoptosis. Isoform 1 positively regulates 
      (induces) apoptosis, while isoform 2 negatively regulates (inhibits) 
      apoptosis. This general term encompasses both functions.
    action: ACCEPT
    reason: This general regulatory term is appropriate as CASP9 is involved in 
      apoptosis regulation through both pro-apoptotic (isoform 1) and 
      anti-apoptotic (isoform 2) mechanisms. The InterPro association correctly 
      identifies this function.
    supported_by:
    - reference_id: deep-research
      supporting_text: 'The CASP9 gene generates two functionally antagonistic isoforms
        through alternative splicing: the pro-apoptotic caspase-9a that retains exons
        3, 4, 5, and 6, and the anti-apoptotic caspase-9b'
- term:
    id: GO:0051604
    label: protein maturation
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: Caspase-9 (isoform 1) processes/matures other proteins including 
      procaspase-3 and procaspase-7 by proteolytic cleavage.
    action: ACCEPT
    reason: The annotation captures caspase-9's role in processing downstream 
      effector caspases from their inactive proforms to active enzymes. This is 
      a core function of initiator caspases.
    supported_by:
    - reference_id: PMID:16352606
      supporting_text: Apaf-1 oligomerizes to produce approximately 1.4-MDa and 
        approximately 700-kDa apoptosome complexes, and the latter complex 
        directly cleaves/activates procaspase-7
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:10206961
  review:
    summary: PMID:10206961 demonstrates caspase-9 binding to Apaf-1 in the 
      apoptosome complex. While "protein binding" is too vague, the specific 
      interaction with Apaf-1 is core to caspase-9 function.
    action: MODIFY
    reason: '"Protein binding" is uninformative. The paper demonstrates CARD-CARD
      interaction between caspase-9 and Apaf-1 in the apoptosome. A more specific
      term should be used.'
    proposed_replacement_terms:
    - id: GO:0004197
      label: cysteine-type endopeptidase activity
    additional_reference_ids:
    - PMID:10206961
    supported_by:
    - reference_id: PMID:10206961
      supporting_text: Such a complex can be isolated using gel filtration 
        chromatography and is by itself sufficient to recruit and activate 
        procaspase-9
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:10376594
  review:
    summary: PMID:10376594 describes the structural basis of procaspase-9 
      recruitment by Apaf-1 via CARD-CARD interactions. "Protein binding" is too
      general.
    action: MODIFY
    reason: The specific interaction is CARD domain binding. A more informative 
      term would capture the CARD-CARD interaction that recruits caspase-9 to 
      the apoptosome.
    proposed_replacement_terms:
    - id: GO:0042802
      label: identical protein binding
    supported_by:
    - reference_id: PMID:10376594
      supporting_text: Structural basis of procaspase-9 recruitment by the 
        apoptotic protease-activating factor 1
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11024045
  review:
    summary: PMID:11024045 describes Livin (BIRC7), an IAP family member that 
      can bind caspases.
    action: KEEP_AS_NON_CORE
    reason: IAP binding is part of caspase regulation but "protein binding" is 
      too vague. The interaction with IAPs is important for regulation but not a
      core function annotation.
    supported_by:
    - reference_id: PMID:11024045
      supporting_text: Livin, a novel inhibitor of apoptosis protein family 
        member
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11084335
  review:
    summary: PMID:11084335 describes ML-IAP (BIRC7) interaction with caspases.
    action: KEEP_AS_NON_CORE
    reason: IAP interaction is regulatory. "Protein binding" is too vague but 
      the interaction is documented.
    supported_by:
    - reference_id: PMID:11084335
      supporting_text: ML-IAP, a novel inhibitor of apoptosis that is 
        preferentially expressed in human melanomas
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11230124
  review:
    summary: PMID:11230124 describes recruitment of caspases to Apaf-1 
      apoptosome and XIAP complexes.
    action: KEEP_AS_NON_CORE
    reason: Documents apoptosome assembly and XIAP regulation. "Protein binding"
      is uninformative but the interactions are relevant.
    supported_by:
    - reference_id: PMID:11230124
      supporting_text: Recruitment, activation and retention of caspases-9 and 
        -3 by Apaf-1 apoptosome and associated XIAP complexes
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11242052
  review:
    summary: PMID:11242052 describes the XIAP-interaction motif in caspase-9 and
      Smac/DIABLO.
    action: KEEP_AS_NON_CORE
    reason: IAP binding motif documentation. The caspase-9/XIAP interaction is 
      well-established for regulation of caspase activity.
    supported_by:
    - reference_id: PMID:11242052
      supporting_text: A conserved XIAP-interaction motif in caspase-9 and 
        Smac/DIABLO regulates caspase activity and apoptosis
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11801603
  review:
    summary: PMID:11801603 describes SMAC interaction with ML-IAP (BIRC7).
    action: KEEP_AS_NON_CORE
    reason: Part of the IAP regulatory network affecting caspase-9 activity.
    supported_by:
    - reference_id: PMID:11801603
      supporting_text: SMAC negatively regulates the anti-apoptotic activity of 
        melanoma inhibitor of apoptosis
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11821383
  review:
    summary: PMID:11821383 describes CARD-8 interaction with caspase-9 via CARD 
      domain. CARD-8 regulates caspase-1 and can interact with caspase-9.
    action: KEEP_AS_NON_CORE
    reason: CARD-8 interaction is regulatory. The paper focuses on caspase-1 
      regulation with caspase-9 interaction being secondary.
    supported_by:
    - reference_id: PMID:11821383
      supporting_text: CARD-8 protein, a new CARD family member that regulates 
        caspase-1 activation and apoptosis
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:12620238
  review:
    summary: PMID:12620238 provides structural mechanism of XIAP-mediated 
      caspase-9 inhibition.
    action: KEEP_AS_NON_CORE
    reason: XIAP binding is a key regulatory mechanism. The structural data 
      confirms the interaction but "protein binding" is too vague.
    supported_by:
    - reference_id: PMID:12620238
      supporting_text: Mechanism of XIAP-mediated inhibition of caspase-9
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:16189514
  review:
    summary: PMID:16189514 is a large-scale proteome mapping study. Individual 
      interactions may not be validated.
    action: KEEP_AS_NON_CORE
    reason: High-throughput study. Interactions should be confirmed by directed 
      studies.
    supported_by:
    - reference_id: PMID:16189514
      supporting_text: Towards a proteome-scale map of the human protein-protein
        interaction network
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:16537496
  review:
    summary: PMID:16537496 describes DCC dependence receptor signaling involving
      caspase-9.
    action: KEEP_AS_NON_CORE
    reason: DCC receptor signaling is a specific pathway involving caspase-9 
      activation. Not a core function but a documented regulatory interaction.
    supported_by:
    - reference_id: PMID:16537496
      supporting_text: The dependence receptor DCC requires lipid raft 
        localization for cell death signaling
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:16936772
  review:
    summary: PMID:16936772 describes integrin-linked kinase (ILK) interaction 
      with caspases.
    action: KEEP_AS_NON_CORE
    reason: ILK-caspase interaction is context-specific for adhesion-dependent 
      apoptosis in leukemia cells.
    supported_by:
    - reference_id: PMID:16936772
      supporting_text: Integrin-linked kinase interacts with caspase-9 and -8 in
        an adhesion-dependent manner
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18022362
  review:
    summary: PMID:18022362 describes IAP antagonists inducing autoubiquitination
      of c-IAPs.
    action: KEEP_AS_NON_CORE
    reason: Part of IAP regulatory network affecting caspase activity.
    supported_by:
    - reference_id: PMID:18022362
      supporting_text: IAP antagonists induce autoubiquitination of c-IAPs, 
        NF-kappaB activation, and TNFalpha-dependent apoptosis
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18723680
  review:
    summary: PMID:18723680 shows caspase-3 and caspase-7 are functionally 
      distinct, with implications for caspase-9-mediated activation.
    action: KEEP_AS_NON_CORE
    reason: Relevant to caspase-9's substrate specificity but "protein binding" 
      is vague.
    supported_by:
    - reference_id: PMID:18723680
      supporting_text: Executioner caspase-3 and caspase-7 are functionally 
        distinct proteases
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19153467
  review:
    summary: PMID:19153467 provides structural data on BIR3 domain of cIAP1 in 
      complex with caspase-9 N-terminal peptide.
    action: KEEP_AS_NON_CORE
    reason: Structural data on IAP-caspase interaction. Regulatory rather than 
      core function.
    supported_by:
    - reference_id: PMID:19153467
      supporting_text: The structure of the BIR3 domain of cIAP1 in complex with
        the N-terminal peptides of SMAC and caspase-9
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19494828
  review:
    summary: PMID:19494828 describes the apoptosome as a proteolytic-based 
      molecular timer.
    action: ACCEPT
    reason: This paper provides important mechanistic insight into 
      caspase-9/Apaf-1 interaction dynamics in the apoptosome. The interaction 
      is core to function though "protein binding" is uninformative.
    supported_by:
    - reference_id: PMID:19494828
      supporting_text: The Apaf-1*procaspase-9 apoptosome complex functions as a
        proteolytic-based molecular timer
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19721007
  review:
    summary: PMID:19721007 describes Netrin-1 signaling in colorectal cancer 
      involving dependence receptors.
    action: KEEP_AS_NON_CORE
    reason: Netrin-1/dependence receptor signaling is a specific context for 
      caspase activation.
    supported_by:
    - reference_id: PMID:19721007
      supporting_text: Netrin-1 up-regulation in inflammatory bowel diseases is 
        required for colorectal cancer progression
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20462491
  review:
    summary: PMID:20462491 provides structure of apoptosome-procaspase-9 CARD 
      complex.
    action: ACCEPT
    reason: Key structural study of the core caspase-9/Apaf-1 CARD interaction. 
      Though "protein binding" is vague, the CARD-CARD interaction is essential 
      for function.
    supported_by:
    - reference_id: PMID:20462491
      supporting_text: Structure of an apoptosome-procaspase-9 CARD complex
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:21827945
  review:
    summary: PMID:21827945 describes holo-apoptosome structure and procaspase-9 
      activation and interactions with caspase-3.
    action: ACCEPT
    reason: Core structural/mechanistic study of the apoptosome. Demonstrates 
      caspase-9 binding to apoptosome and interactions with caspase-3.
    supported_by:
    - reference_id: PMID:21827945
      supporting_text: Activation of procaspase-9 on the apoptosome is a pivotal
        step in the intrinsic cell death pathway
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23516580
  review:
    summary: PMID:23516580 describes E. coli NleF effector as a caspase 
      inhibitor that binds caspase-9.
    action: KEEP_AS_NON_CORE
    reason: Pathogen effector binding is context-specific for microbial 
      infection.
    supported_by:
    - reference_id: PMID:23516580
      supporting_text: The E. coli effector protein NleF is a caspase inhibitor
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25241761
  review:
    summary: High-throughput proximity ligation study.
    action: KEEP_AS_NON_CORE
    reason: Large-scale study requiring validation of individual interactions.
    supported_by:
    - reference_id: PMID:25241761
      supporting_text: Using an in situ proximity ligation assay to 
        systematically profile endogenous protein-protein interactions
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25416956
  review:
    summary: Proteome-scale interactome mapping study.
    action: KEEP_AS_NON_CORE
    reason: High-throughput study. Individual interactions need validation.
    supported_by:
    - reference_id: PMID:25416956
      supporting_text: A proteome-scale map of the human interactome network
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25502805
  review:
    summary: Massively parallel cloning and phenotyping study.
    action: KEEP_AS_NON_CORE
    reason: High-throughput study.
    supported_by:
    - reference_id: PMID:25502805
      supporting_text: A massively parallel pipeline to clone DNA variants and 
        examine molecular phenotypes
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25519916
  review:
    summary: EHEC-host interactome study identifying translocated intimin 
      receptor targets.
    action: KEEP_AS_NON_CORE
    reason: Pathogen-host interaction context.
    supported_by:
    - reference_id: PMID:25519916
      supporting_text: The EHEC-host interactome reveals novel targets for the 
        translocated intimin receptor
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:27107012
  review:
    summary: Barcode Fusion Genetics protein interaction screen.
    action: KEEP_AS_NON_CORE
    reason: High-throughput screening method.
    supported_by:
    - reference_id: PMID:27107012
      supporting_text: Pooled-matrix protein interaction screens using Barcode 
        Fusion Genetics
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29997244
  review:
    summary: LuTHy two-hybrid technology for protein interaction mapping.
    action: KEEP_AS_NON_CORE
    reason: High-throughput interaction mapping study.
    supported_by:
    - reference_id: PMID:29997244
      supporting_text: 'LuTHy: a double-readout bioluminescence-based two-hybrid technology'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:31467278
  review:
    summary: Binary interactome mapping optimization study.
    action: KEEP_AS_NON_CORE
    reason: Methodological study for interaction mapping.
    supported_by:
    - reference_id: PMID:31467278
      supporting_text: Maximizing binary interactome mapping with a minimal 
        number of assays
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:31515488
  review:
    summary: Study of protein interaction disruption by genetic variants.
    action: KEEP_AS_NON_CORE
    reason: Population genetics study of interaction disruption.
    supported_by:
    - reference_id: PMID:31515488
      supporting_text: Extensive disruption of protein interactions by genetic 
        variants across the allele frequency spectrum
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: Reference map of human binary protein interactome.
    action: KEEP_AS_NON_CORE
    reason: Large-scale interactome reference study.
    supported_by:
    - reference_id: PMID:32296183
      supporting_text: A reference map of the human binary protein interactome
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9390557
  review:
    summary: PMID:9390557 is a landmark paper demonstrating caspase-9/Apaf-1 
      CARD-CARD interaction in apoptosome formation.
    action: ACCEPT
    reason: Foundational paper on caspase-9 function. Demonstrates the core 
      CARD-CARD interaction with Apaf-1 essential for apoptosome formation and 
      caspase activation.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: Caspase-9 and Apaf-1 bind to each other via their 
        respective NH2-terminal CED-3 homologous domains in the presence of 
        cytochrome c and dATP
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9922454
  review:
    summary: PMID:9922454 describes the caspase cascade with caspase-9 dependent
      activation of downstream caspases.
    action: ACCEPT
    reason: Demonstrates caspase-9 interaction with and processing of downstream
      caspases (caspase-2, -3, -6, -7, -8, -10). Core function of initiator 
      caspase.
    supported_by:
    - reference_id: PMID:9922454
      supporting_text: 'Ordering the cytochrome c-initiated caspase cascade: hierarchical
        activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent
        manner'
- term:
    id: GO:0001666
    label: response to hypoxia
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Caspase-9 is activated during hypoxia-induced apoptosis. Recent 
      research shows non-apoptotic endothelial caspase-9 signaling in 
      hypoxia-ischemia.
    action: ACCEPT
    reason: 'Deep research confirms: "In a mouse model of retinal vein occlusion (RVO),
      pharmacological inhibition or genetic deletion of caspase-9 specifically from
      endothelial cells significantly reduces vascular edema." Hypoxia triggers intrinsic
      apoptotic pathway.'
    supported_by:
    - reference_id: deep-research
      supporting_text: endothelial caspase-9 activation following 
        hypoxia-ischemia appears to occur independently of apoptosis
- term:
    id: GO:0001822
    label: kidney development
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Caspase-mediated apoptosis plays roles in kidney development. This 
      is a pleiotropic developmental process.
    action: KEEP_AS_NON_CORE
    reason: Apoptosis is involved in kidney development but this is not a core 
      function of caspase-9. The annotation is from ortholog transfer (Ensembl 
      Compara).
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0002931
    label: response to ischemia
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Caspase-9 is activated in ischemic injury, both through apoptotic 
      and non-apoptotic mechanisms in endothelial cells.
    action: ACCEPT
    reason: 'Deep research confirms: "In a mouse model of retinal vein occlusion (RVO),
      pharmacological inhibition or genetic deletion of caspase-9...significantly
      reduces vascular edema, restores vascular integrity, and provides robust neuroprotection."'
    supported_by:
    - reference_id: deep-research
      supporting_text: non-apoptotic endothelial caspase-9 signaling as a 
        critical mediator of ischemic injury in hypoxia-ischemia models
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Nuclear localization of caspase-9 is less well-established than 
      cytosolic localization. Some reports suggest translocation during 
      apoptosis.
    action: KEEP_AS_NON_CORE
    reason: Caspase-9 is primarily cytosolic. Nuclear localization may occur in 
      specific contexts but is not the primary site of function. The annotation 
      is from ortholog transfer and should be viewed with caution.
    supported_by:
    - reference_id: PMID:12782307
      supporting_text: caspase-9 is in the cytoplasm of non-apoptotic pituitary 
        cells
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Cytoplasmic localization is well-established. Redundant with IBA 
      annotation.
    action: ACCEPT
    reason: Consistent with IBA annotation and experimental evidence. Caspase-9 
      is predominantly cytoplasmic.
    supported_by:
    - reference_id: PMID:12782307
      supporting_text: caspase-9 is in the cytoplasm of non-apoptotic pituitary 
        cells
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Cytosolic localization confirmed. Redundant with IBA and TAS 
      annotations.
    action: ACCEPT
    reason: Consistent with other annotations and experimental evidence.
    supported_by:
    - reference_id: PMID:12782307
      supporting_text: caspase-9 is in the cytoplasm of non-apoptotic pituitary 
        cells
- term:
    id: GO:0016485
    label: protein processing
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Caspase-9 processes procaspases-3 and -7 by proteolytic cleavage. 
      This is a core function.
    action: ACCEPT
    reason: Caspase-9 processes its substrates (procaspase-3, procaspase-7) to 
      their mature forms. This is the primary enzymatic function.
    supported_by:
    - reference_id: PMID:16352606
      supporting_text: Apaf-1 oligomerizes to produce approximately 1.4-MDa and 
        approximately 700-kDa apoptosome complexes, and the latter complex 
        directly cleaves/activates procaspase-7
- term:
    id: GO:0032025
    label: response to cobalt ion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Cobalt ions can induce hypoxia-like responses. Caspase-9 may be 
      activated in this context.
    action: KEEP_AS_NON_CORE
    reason: Cobalt-induced response is likely through hypoxia mimicry. Not a 
      core function but an experimental context. Annotation from ortholog 
      transfer.
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0032355
    label: response to estradiol
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Estradiol can have anti-apoptotic effects that may involve caspase 
      regulation.
    action: KEEP_AS_NON_CORE
    reason: Hormone response is context-specific. Annotation from ortholog 
      transfer. Not a core function.
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0032496
    label: response to lipopolysaccharide
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: LPS can trigger apoptotic pathways in various cell types.
    action: KEEP_AS_NON_CORE
    reason: LPS response is context-specific, particularly relevant to immune 
      cells. Annotation from ortholog transfer.
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0034349
    label: glial cell apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Caspase-9 is involved in glial cell apoptosis as part of CNS 
      development and disease.
    action: KEEP_AS_NON_CORE
    reason: 'Cell-type specific apoptotic process. Not a core function but consistent
      with caspase-9''s role in CNS development. CRITICAL: Only isoform 1 would positively
      regulate this.'
    supported_by:
    - reference_id: deep-research
      supporting_text: mice lacking caspase-9 die perinatally with severe brain 
        abnormalities
- term:
    id: GO:0043065
    label: positive regulation of apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: 'CRITICAL ISOFORM ANNOTATION: This annotation is ONLY true for isoform
      1 (Caspase-9L/Alpha). Isoform 2 (Caspase-9S/Beta) is a DOMINANT-NEGATIVE INHIBITOR
      that NEGATIVELY regulates apoptosis.'
    action: ACCEPT
    reason: Isoform 1 does positively regulate apoptosis by activating effector 
      caspases. However, the annotation should ideally be isoform-specific. The 
      IEA annotation applies to the canonical pro-apoptotic function.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: caspase-9 is the most upstream member of the apoptotic 
        protease cascade
    - reference_id: deep-research
      supporting_text: the pro-apoptotic caspase-9a that retains exons 3, 4, 5, 
        and 6, and the anti-apoptotic caspase-9b
- term:
    id: GO:0045471
    label: response to ethanol
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Ethanol can induce apoptosis in various tissues including liver and
      neurons.
    action: KEEP_AS_NON_CORE
    reason: Toxicological response context. Annotation from ortholog transfer. 
      Not a core function.
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0071549
    label: cellular response to dexamethasone stimulus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Dexamethasone can induce apoptosis in some cell types.
    action: KEEP_AS_NON_CORE
    reason: Glucocorticoid response is context-specific. Annotation from 
      ortholog transfer.
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0071680
    label: response to indole-3-methanol
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Indole-3-carbinol is a phytochemical that can affect apoptotic 
      pathways.
    action: KEEP_AS_NON_CORE
    reason: Specific chemical response. Not a core function. Annotation from 
      ortholog transfer.
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0071887
    label: leukocyte apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Caspase-9 is involved in leukocyte apoptosis as part of immune 
      regulation.
    action: KEEP_AS_NON_CORE
    reason: 'Cell-type specific apoptotic process. The intrinsic pathway operates
      in leukocytes but this is not a core function annotation. CRITICAL: Only isoform
      1 promotes this.'
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0072347
    label: response to anesthetic
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Some anesthetics can induce neuronal apoptosis involving caspase-9.
    action: KEEP_AS_NON_CORE
    reason: Specific pharmacological context. Annotation from ortholog transfer.
    supported_by:
    - reference_id: GO_REF:0000107
      supporting_text: Automatic transfer of experimentally verified manual GO 
        annotation data to orthologs
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-114259
  review:
    summary: 'Reactome pathway annotation for caspase-9 cleavage. CRITICAL: This catalytic
      activity is ONLY present in isoform 1.'
    action: ACCEPT
    reason: Reactome correctly annotates the catalytic activity in the context 
      of apoptosome-mediated procaspase-9 cleavage to active caspase-9.
    supported_by:
    - reference_id: Reactome:R-HSA-114259
      supporting_text: Procaspase‑9 is processed in an ATP‑dependent manner 
        following association with APAF1 and cytochrome c (CYCS) within the 
        apoptosome complex
- term:
    id: GO:0097193
    label: intrinsic apoptotic signaling pathway
  evidence_type: NAS
  original_reference_id: PMID:10206961
  review:
    summary: 'PMID:10206961 demonstrates caspase-9 activation in the apoptosome as
      the key step in the intrinsic apoptotic pathway. CRITICAL: Isoform 1 activates
      while isoform 2 inhibits this pathway.'
    action: ACCEPT
    reason: Core annotation for caspase-9 function. The paper demonstrates 
      apoptosome formation and procaspase-9 activation.
    supported_by:
    - reference_id: PMID:10206961
      supporting_text: Such a complex can be isolated using gel filtration 
        chromatography and is by itself sufficient to recruit and activate 
        procaspase-9
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: IDA
  original_reference_id: PMID:16352606
  review:
    summary: PMID:16352606 demonstrates caspase-9 directly cleaving and 
      activating caspase-7 in the apoptosome. This is direct experimental 
      evidence for the catalytic activity (isoform 1 only).
    action: ACCEPT
    reason: Direct experimental demonstration of caspase-9 enzymatic activity in
      processing caspase-7.
    supported_by:
    - reference_id: PMID:16352606
      supporting_text: Apaf-1 oligomerizes to produce approximately 1.4-MDa and 
        approximately 700-kDa apoptosome complexes, and the latter complex 
        directly cleaves/activates procaspase-7
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: IDA
  original_reference_id: PMID:16916640
  review:
    summary: PMID:16916640 uses engineered hybrid dimers to track caspase-7 
      activation by caspase-9, demonstrating the endopeptidase activity (isoform
      1).
    action: ACCEPT
    reason: Direct experimental demonstration of caspase-9 enzymatic activity in
      processing caspase-7 using sophisticated biochemical approaches.
    supported_by:
    - reference_id: PMID:16916640
      supporting_text: A transient intermediate of singly cleaved dimeric 
        caspase-7 can be found in a cell-free model of apoptosis induction
- term:
    id: GO:0043065
    label: positive regulation of apoptotic process
  evidence_type: IMP
  original_reference_id: PMID:11821383
  review:
    summary: 'PMID:11821383 describes CARD-8 interaction with caspase-9. The paper
      shows CARD-8 overexpression induces apoptosis. CRITICAL: This pro-apoptotic
      function is isoform 1 specific.'
    action: ACCEPT
    reason: The study demonstrates caspase-9's role in apoptosis induction 
      through CARD-domain interactions. The mutant phenotype evidence supports 
      positive regulation of apoptosis.
    supported_by:
    - reference_id: PMID:11821383
      supporting_text: Overexpression of CARD-8 can also induce apoptosis in 
        transfected cells
- term:
    id: GO:0006974
    label: DNA damage response
  evidence_type: IMP
  original_reference_id: PMID:15657060
  review:
    summary: PMID:15657060 demonstrates c-Abl phosphorylates caspase-9 in DNA 
      damage response, with mutant phenotype evidence.
    action: ACCEPT
    reason: Direct experimental evidence using Y153F mutant showing attenuated 
      DNA damage-induced caspase-9 processing and apoptosis.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: Caspase-9(Y153F) also attenuated DNA damage-induced 
        processing of caspase-9 to p35, activation of caspase-3, and apoptosis
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9627089
  review:
    summary: Reactome pathway annotation for caspase-9 localization in 
      phosphorylation reaction.
    action: ACCEPT
    reason: Consistent with other cytosolic localization annotations. Caspase-9 
      is phosphorylated at T412 in the cytosol.
    supported_by:
    - reference_id: Reactome:R-HSA-9627089
      supporting_text: CASP9 is phosphorylated at T412
- term:
    id: GO:0097193
    label: intrinsic apoptotic signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:35446120
  review:
    summary: PMID:35446120 shows Chromobacterium CopC effector ADP-riboxanates 
      caspase-9 to inhibit intrinsic apoptotic pathway. This demonstrates 
      caspase-9's role in the pathway (isoform 1).
    action: ACCEPT
    reason: The study demonstrates caspase-9's essential role in intrinsic 
      apoptotic signaling by showing that pathogen effector modification blocks 
      this pathway.
    supported_by:
    - reference_id: PMID:35446120
      supporting_text: Calmodulin Binding Activates Chromobacterium CopC 
        Effector to ADP-Riboxanate Host Apoptotic Caspases
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:12782307
  review:
    summary: PMID:12782307 shows caspase-9 redistributes from cytoplasm to 
      mitochondria during apoptosis.
    action: ACCEPT
    reason: Direct experimental evidence of caspase-9 mitochondrial localization
      during apoptosis. The paper shows "activation of apoptosis with rotenone 
      triggers the redistribution of caspase-9 to mitochondria."
    supported_by:
    - reference_id: PMID:12782307
      supporting_text: The activation of apoptosis with rotenone triggers the 
        redistribution of caspase-9 to mitochondria
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: IDA
  original_reference_id: PMID:27889207
  review:
    summary: PMID:27889207 demonstrates PAK2 phosphorylation of caspase-7 blocks
      its activation by caspase-9, providing evidence for caspase-9 enzymatic 
      activity (isoform 1).
    action: ACCEPT
    reason: The study demonstrates caspase-9's enzymatic activity in caspase-7 
      activation.
    supported_by:
    - reference_id: PMID:27889207
      supporting_text: Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks 
        Apoptotic Activity by Two Distinct Mechanisms
- term:
    id: GO:0051604
    label: protein maturation
  evidence_type: IDA
  original_reference_id: PMID:16352606
  review:
    summary: PMID:16352606 shows caspase-9 directly matures procaspase-7 to 
      active caspase-7 (isoform 1 function).
    action: ACCEPT
    reason: Direct experimental evidence of caspase-9 processing procaspase-7 to
      mature enzyme.
    supported_by:
    - reference_id: PMID:16352606
      supporting_text: Apaf-1 oligomerizes to produce approximately 1.4-MDa and 
        approximately 700-kDa apoptosome complexes, and the latter complex 
        directly cleaves/activates procaspase-7
- term:
    id: GO:0051604
    label: protein maturation
  evidence_type: IDA
  original_reference_id: PMID:16916640
  review:
    summary: PMID:16916640 demonstrates caspase-7 maturation by caspase-9 using 
      hybrid dimers (isoform 1 function).
    action: ACCEPT
    reason: Direct experimental evidence using sophisticated biochemical 
      approaches to demonstrate procaspase-7 maturation.
    supported_by:
    - reference_id: PMID:16916640
      supporting_text: The processed domain of this singly cleaved zymogen has 
        the same catalytic activity as a domain of fully active caspase-7
- term:
    id: GO:1900119
    label: positive regulation of execution phase of apoptosis
  evidence_type: IDA
  original_reference_id: PMID:16916640
  review:
    summary: 'PMID:16916640 demonstrates caspase-9 activates caspase-7, which executes
      apoptosis. CRITICAL: This is isoform 1 specific.'
    action: ACCEPT
    reason: The execution phase of apoptosis is triggered by activation of 
      executioner caspases (caspase-3 and -7) by caspase-9. Direct experimental 
      evidence.
    supported_by:
    - reference_id: PMID:16916640
      supporting_text: Our study demonstrates the efficiency by which the 
        executioner caspases are activated in vivo
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: IMP
  original_reference_id: PMID:21980415
  review:
    summary: PMID:21980415 identifies conserved anti-apoptotic protein 
      modulating mitochondrial apoptosis pathway, using mutant phenotypes to 
      demonstrate caspase-9 activity.
    action: ACCEPT
    reason: Mutant phenotype evidence for caspase-9 catalytic activity in 
      apoptosis.
    supported_by:
    - reference_id: PMID:21980415
      supporting_text: Identification of a conserved anti-apoptotic protein that
        modulates the mitochondrial apoptosis pathway
- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IMP
  original_reference_id: PMID:15069058
  review:
    summary: PMID:15069058 describes BRCC2, a BH3-domain protein that induces 
      apoptosis in a caspase-dependent manner.
    action: ACCEPT
    reason: Mutant phenotype evidence for caspase-9 role in apoptosis through 
      BH3 domain protein interactions.
    supported_by:
    - reference_id: PMID:15069058
      supporting_text: BRCC2, a novel BH3-like domain-containing protein, 
        induces apoptosis in a caspase-dependent manner
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: IDA
  original_reference_id: PMID:16920334
  review:
    summary: PMID:16920334 examines Cop protective role in caspase-mediated cell
      death (isoform 1 function).
    action: ACCEPT
    reason: Direct assay evidence for caspase-9 catalytic activity in cell 
      death.
    supported_by:
    - reference_id: PMID:16920334
      supporting_text: Protective role of Cop in 
        Rip2/caspase-1/caspase-4-mediated HeLa cell death
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11821383
  review:
    summary: PMID:11821383 shows CARD-8 binds to caspase-9 via CARD domain 
      interaction.
    action: KEEP_AS_NON_CORE
    reason: CARD domain interaction is documented but "protein binding" is 
      uninformative. The CARD-CARD interaction is regulatory.
    supported_by:
    - reference_id: PMID:11821383
      supporting_text: CARD-8 binds also to ICEBERG and pseudo-ICE
- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: IDA
  original_reference_id: PMID:11821383
  review:
    summary: PMID:11821383 identifies caspase-9 in protein complexes with 
      CARD-8.
    action: KEEP_AS_NON_CORE
    reason: Generic complex annotation. The apoptosome is the key functional 
      complex for caspase-9.
    supported_by:
    - reference_id: PMID:11821383
      supporting_text: CARD-8 interacts physically with caspase-1
- term:
    id: GO:0008233
    label: peptidase activity
  evidence_type: IDA
  original_reference_id: PMID:19740745
  review:
    summary: PMID:19740745 shows truncated p23 disrupts Hsp90 function affecting
      telomerase. Caspase-9 peptidase activity is involved (isoform 1).
    action: ACCEPT
    reason: Direct assay evidence for caspase-9 peptidase activity. Parent term 
      of cysteine-type endopeptidase activity.
    supported_by:
    - reference_id: PMID:19740745
      supporting_text: A truncated form of p23 down-regulates telomerase 
        activity via disruption of Hsp90 function
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19255499
  review:
    summary: PMID:19255499 shows HIP1R interacts with BCL2L10 which affects 
      BAK-dependent cell death.
    action: KEEP_AS_NON_CORE
    reason: BCL2L10 interaction affects mitochondrial apoptosis pathway. 
      Regulatory interaction.
    supported_by:
    - reference_id: PMID:19255499
      supporting_text: HIP1R interacts with a member of Bcl-2 family, BCL2L10, 
        and induces BAK-dependent cell death
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-114252
  review:
    summary: Reactome pathway annotation for procaspase-3 cleavage by 
      apoptosome.
    action: ACCEPT
    reason: Consistent with cytosolic localization of the apoptosome complex 
      where caspase-9 cleaves procaspase-3.
    supported_by:
    - reference_id: Reactome:R-HSA-114252
      supporting_text: Cleavage of Procaspase-3 by the apoptosome
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-114259
  review:
    summary: Reactome annotation for procaspase-9 cleavage.
    action: ACCEPT
    reason: Consistent with cytosolic localization of the apoptosome.
    supported_by:
    - reference_id: Reactome:R-HSA-114259
      supporting_text: Procaspase‑9 is processed in an ATP‑dependent manner 
        following association with APAF1 and cytochrome c (CYCS) within the 
        apoptosome complex
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-114261
  review:
    summary: Reactome annotation for procaspase-7 cleavage by apoptosome.
    action: ACCEPT
    reason: Consistent with cytosolic localization.
    supported_by:
    - reference_id: Reactome:R-HSA-114261
      supporting_text: Cleavage of Procaspase-7 by the apoptosome
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-373700
  review:
    summary: Reactome annotation for caspase-9 binding to DCC:DIP13alpha 
      complex.
    action: ACCEPT
    reason: Consistent with cytosolic localization for dependence receptor 
      signaling.
    supported_by:
    - reference_id: Reactome:R-HSA-373700
      supporting_text: Caspase-9 binds DCC:DIP13alpha complex
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-418845
  review:
    summary: Reactome annotation for caspase-3 activation.
    action: ACCEPT
    reason: Consistent with cytosolic localization for caspase cascade.
    supported_by:
    - reference_id: Reactome:R-HSA-418845
      supporting_text: Activation of caspase-3
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6804596
  review:
    summary: Reactome annotation for APAF1:CYCS binding APIP.
    action: ACCEPT
    reason: Consistent with cytosolic localization of apoptosome components.
    supported_by:
    - reference_id: Reactome:R-HSA-6804596
      supporting_text: APAF1:CYCS binds APIP
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6805426
  review:
    summary: Reactome annotation for CARD8 binding to CASP9(1-416).
    action: ACCEPT
    reason: Consistent with cytosolic localization.
    supported_by:
    - reference_id: Reactome:R-HSA-6805426
      supporting_text: CARD8 binds CASP9(1-416)
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9627056
  review:
    summary: Reactome annotation for procaspase-9 dimer formation.
    action: ACCEPT
    reason: Consistent with cytosolic localization for dimerization.
    supported_by:
    - reference_id: Reactome:R-HSA-9627056
      supporting_text: Procaspase 9 forms dimer
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9627078
  review:
    summary: Reactome annotation for XIAP binding CASP9.
    action: ACCEPT
    reason: Consistent with cytosolic localization for IAP regulation.
    supported_by:
    - reference_id: Reactome:R-HSA-9627078
      supporting_text: X‑linked inhibitor‑of‑apoptosis protein (XIAP) associates
        with the cleaved form of CASP9
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: PMID:17167422
  review:
    summary: PMID:17167422 shows Hsp70 regulates erythropoiesis by preventing 
      caspase-3 cleavage of GATA-1 in the cytosol.
    action: ACCEPT
    reason: Direct experimental evidence for cytosolic caspase activity during 
      erythroid differentiation.
    supported_by:
    - reference_id: PMID:17167422
      supporting_text: At the onset of caspase activation, Hsp70 co-localizes 
        and interacts with GATA-1 in the nucleus
- term:
    id: GO:0030220
    label: platelet formation
  evidence_type: TAS
  original_reference_id: PMID:18309324
  review:
    summary: PMID:18309324 reviews non-apoptotic functions of apoptotic 
      effectors, including roles in platelet formation.
    action: KEEP_AS_NON_CORE
    reason: Non-apoptotic function of caspases in platelet formation is 
      documented. This represents a specialized function distinct from core 
      apoptotic role.
    supported_by:
    - reference_id: PMID:18309324
      supporting_text: multiple studies indicate that the mammalian orthologs of
        these C. elegans proteins (i.e. caspases, Apaf-1 and multidomain 
        proteins of the Bcl-2 family) participate in cell death-unrelated 
        processes
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-114256
  review:
    summary: Reactome annotation for CYCS:APAF1 binding procaspase-9.
    action: ACCEPT
    reason: Consistent with cytosolic localization of apoptosome assembly.
    supported_by:
    - reference_id: Reactome:R-HSA-114256
      supporting_text: CYCS:APAF1 binds procaspase-9
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-198621
  review:
    summary: Reactome annotation for AKT phosphorylates caspase-9.
    action: ACCEPT
    reason: Consistent with cytosolic localization for AKT-mediated regulation.
    supported_by:
    - reference_id: Reactome:R-HSA-198621
      supporting_text: AKT phosphorylates caspase-9
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2399985
  review:
    summary: Reactome annotation for AKT1 E17K mutant phosphorylates caspase-9.
    action: ACCEPT
    reason: Consistent with cytosolic localization.
    supported_by:
    - reference_id: Reactome:R-HSA-2399985
      supporting_text: AKT1 E17K mutant phosphorylates caspase-9
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6804596
  review:
    summary: Duplicate annotation - same as earlier entry.
    action: ACCEPT
    reason: Consistent with cytosolic localization.
    supported_by:
    - reference_id: Reactome:R-HSA-6804596
      supporting_text: APAF1:CYCS binds APIP
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6805426
  review:
    summary: Duplicate annotation - same as earlier entry.
    action: ACCEPT
    reason: Consistent with cytosolic localization.
    supported_by:
    - reference_id: Reactome:R-HSA-6805426
      supporting_text: CARD8 binds CASP9(1-416)
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9627056
  review:
    summary: Duplicate annotation - same as earlier entry.
    action: ACCEPT
    reason: Consistent with cytosolic localization.
    supported_by:
    - reference_id: Reactome:R-HSA-9627056
      supporting_text: Procaspase 9 forms dimer
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15657060
  review:
    summary: PMID:15657060 shows c-Abl directly binds caspase-9 via SH3 domain.
    action: ACCEPT
    reason: c-Abl/caspase-9 interaction is functionally important for DNA damage
      response. Though "protein binding" is vague, the interaction is core to 
      DNA damage-induced apoptosis.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: c-Abl binds directly to caspase-9
- term:
    id: GO:0006974
    label: DNA damage response
  evidence_type: IDA
  original_reference_id: PMID:15657060
  review:
    summary: PMID:15657060 provides direct assay evidence for caspase-9 in DNA 
      damage response through c-Abl-mediated phosphorylation.
    action: ACCEPT
    reason: Direct experimental demonstration of caspase-9 activation in DNA 
      damage response via c-Abl phosphorylation at Tyr-153.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: c-Abl phosphorylates caspase-9 on Tyr-153 in vitro and in
        cells treated with DNA damaging agents
- term:
    id: GO:0008630
    label: intrinsic apoptotic signaling pathway in response to DNA damage
  evidence_type: IMP
  original_reference_id: PMID:15657060
  review:
    summary: PMID:15657060 demonstrates Y153F mutant attenuates DNA 
      damage-induced caspase-9 processing and apoptosis.
    action: ACCEPT
    reason: Mutant phenotype evidence for caspase-9 role in intrinsic apoptotic 
      signaling in response to DNA damage.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: Caspase-9(Y153F) also attenuated DNA damage-induced 
        processing of caspase-9 to p35, activation of caspase-3, and apoptosis
- term:
    id: GO:0019901
    label: protein kinase binding
  evidence_type: IDA
  original_reference_id: PMID:15657060
  review:
    summary: PMID:15657060 demonstrates caspase-9 binds c-Abl tyrosine kinase.
    action: ACCEPT
    reason: Direct experimental evidence for caspase-9 binding to c-Abl kinase. 
      This is a more informative term than generic "protein binding".
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: c-Abl binds directly to caspase-9
- term:
    id: GO:0034644
    label: cellular response to UV
  evidence_type: IDA
  original_reference_id: PMID:15657060
  review:
    summary: PMID:15657060 demonstrates caspase-9 activation in response to UV 
      irradiation via c-Abl.
    action: ACCEPT
    reason: Direct experimental evidence for caspase-9 role in UV response. The 
      Y153F mutant attenuates UV irradiation-induced apoptosis.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: Caspase-9(Y153F) also attenuated DNA damage-induced 
        processing of caspase-9 to p35, activation of caspase-3, and apoptosis
- term:
    id: GO:0042770
    label: signal transduction in response to DNA damage
  evidence_type: IDA
  original_reference_id: PMID:15657060
  review:
    summary: PMID:15657060 shows c-Abl-mediated signal transduction to caspase-9
      in DNA damage response.
    action: ACCEPT
    reason: Direct experimental evidence for caspase-9 role in DNA damage signal
      transduction through c-Abl kinase.
    supported_by:
    - reference_id: PMID:15657060
      supporting_text: c-Abl tyrosine kinase regulates caspase-9 autocleavage in
        the apoptotic response to DNA damage
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11350957
  review:
    summary: PMID:11350957 describes proapoptotic caspase-2 and caspase-9 
      binding protein.
    action: KEEP_AS_NON_CORE
    reason: Documents a caspase-binding protein. "Protein binding" is 
      uninformative.
    supported_by:
    - reference_id: PMID:11350957
      supporting_text: Characterization of a novel proapoptotic caspase-2- and 
        caspase-9-binding protein
- term:
    id: GO:0043293
    label: apoptosome
  evidence_type: IDA
  original_reference_id: PMID:21827945
  review:
    summary: PMID:21827945 provides structural evidence for caspase-9 as a 
      component of the apoptosome.
    action: ACCEPT
    reason: 'Key structural study demonstrating caspase-9 localization to the apoptosome.
      CRITICAL: Both isoforms can bind Apaf-1 in the apoptosome, but with opposite
      effects (isoform 1 activates cascade, isoform 2 inhibits).'
    supported_by:
    - reference_id: PMID:21827945
      supporting_text: Activation of procaspase-9 on the apoptosome is a pivotal
        step in the intrinsic cell death pathway
- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: TAS
  original_reference_id: PMID:8663294
  review:
    summary: PMID:8663294 is the original paper characterizing ICE-LAP6 
      (caspase-9) as an apoptosis-inducing caspase.
    action: ACCEPT
    reason: Foundational paper demonstrating caspase-9 (ICE-LAP6) induces 
      apoptosis when overexpressed and is activated by granzyme B.
    supported_by:
    - reference_id: PMID:8663294
      supporting_text: Overexpression of ICE-LAP6 induces apoptosis in MCF7 
        breast carcinoma cells
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11069302
  review:
    summary: PMID:11069302 describes survivin interaction with caspase-9.
    action: KEEP_AS_NON_CORE
    reason: Survivin is an IAP family member that regulates caspase-9 activity. 
      Regulatory interaction.
    supported_by:
    - reference_id: PMID:11069302
      supporting_text: Regulation of apoptosis at cell division by p34cdc2 
        phosphorylation of survivin
- term:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  evidence_type: TAS
  original_reference_id: PMID:9390557
  review:
    summary: PMID:9390557 is the landmark paper demonstrating caspase-9 
      catalytic activity in the intrinsic pathway (isoform 1).
    action: ACCEPT
    reason: Foundational paper demonstrating caspase-9 cleaves and activates 
      caspase-3.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: Activated caspase-9 in turn cleaves and activates 
        caspase-3
- term:
    id: GO:0008047
    label: enzyme activator activity
  evidence_type: TAS
  original_reference_id: PMID:9390557
  review:
    summary: PMID:9390557 demonstrates caspase-9 activates caspase-3 (isoform 1 
      function).
    action: ACCEPT
    reason: Caspase-9 functions as an enzyme activator by cleaving and 
      activating downstream effector caspases. This captures the initiator 
      caspase function.
    supported_by:
    - reference_id: PMID:9390557
      supporting_text: Activated caspase-9 in turn cleaves and activates 
        caspase-3
- term:
    id: GO:0043066
    label: negative regulation of apoptotic process
  evidence_type: TAS
  original_reference_id: PMID:10070954
  review:
    summary: 'MISSING ANNOTATION: Caspase-9S (isoform 2, P55211-2) is a dominant-negative
      inhibitor of apoptosis. UniProt explicitly states "Isoform 2: Lacks activity
      is an dominant-negative inhibitor of caspase-9." This annotation is CRITICAL
      for understanding CASP9 biology.'
    action: NEW
    reason: Isoform 2 (Caspase-9S/Beta) lacks the catalytic domain and competes 
      with isoform 1 for Apaf-1 binding, thereby inhibiting apoptosis. This is a
      dominant-negative mechanism where the 9L/9S ratio determines apoptotic 
      sensitivity. PMID:10070954 characterizes this isoform. Cancer cells often 
      shift ratio towards 9S to evade apoptosis.
    supported_by:
    - reference_id: PMID:10070954
      supporting_text: Identification of an endogenous dominant-negative short 
        isoform of caspase-9 that can regulate apoptosis
    - reference_id: deep-research
      supporting_text: the anti-apoptotic caspase-9b that excludes these 
        exons...caspase-9b lacks the core catalytic domain and functions as a 
        dominant-negative inhibitor of caspase-9a
- term:
    id: GO:0030234
    label: enzyme regulator activity
  evidence_type: NAS
  review:
    summary: Added to align core_functions with existing annotations.
    action: NEW
    reason: Core function term not present in existing_annotations.
    supported_by:
    - reference_id: PMID:10070954
      supporting_text: Identification of an endogenous dominant-negative short 
        isoform of caspase-9 that can regulate apoptosis
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with 
    GO terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data
    to orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning 
    models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10070954
  title: Identification of an endogenous dominant-negative short isoform of 
    caspase-9 that can regulate apoptosis.
  findings:
  - statement: Caspase-9S (isoform 2) lacks catalytic domain and acts as 
      dominant-negative inhibitor
- id: PMID:10206961
  title: An APAF-1.cytochrome c multimeric complex is a functional apoptosome 
    that activates procaspase-9.
  findings:
  - statement: Apoptosome recruits and activates procaspase-9
  - statement: Stoichiometric ratio of procaspase-9 to APAF-1 is approximately 1
      to 1
- id: PMID:10376594
  title: Structural basis of procaspase-9 recruitment by the apoptotic 
    protease-activating factor 1.
  findings:
  - statement: CARD-CARD interaction between caspase-9 and Apaf-1
- id: PMID:11024045
  title: Livin, a novel inhibitor of apoptosis protein family member.
  findings: []
- id: PMID:11069302
  title: Regulation of apoptosis at cell division by p34cdc2 phosphorylation of 
    survivin.
  findings: []
- id: PMID:11084335
  title: ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed
    in human melanomas.
  findings: []
- id: PMID:11230124
  title: Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 
    apoptosome and associated XIAP complexes.
  findings: []
- id: PMID:11242052
  title: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO 
    regulates caspase activity and apoptosis.
  findings: []
- id: PMID:11350957
  title: Characterization of a novel proapoptotic caspase-2- and 
    caspase-9-binding protein.
  findings: []
- id: PMID:11801603
  title: SMAC negatively regulates the anti-apoptotic activity of melanoma 
    inhibitor of apoptosis (ML-IAP).
  findings: []
- id: PMID:11821383
  title: CARD-8 protein, a new CARD family member that regulates caspase-1 
    activation and apoptosis.
  findings: []
- id: PMID:12620238
  title: Mechanism of XIAP-mediated inhibition of caspase-9.
  findings: []
- id: PMID:12782307
  title: Apoptosis triggered redistribution of caspase-9 from cytoplasm to 
    mitochondria.
  findings:
  - statement: Caspase-9 is cytoplasmic in non-apoptotic cells
  - statement: Redistributes to mitochondria during apoptosis
- id: PMID:15069058
  title: BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in
    a caspase-dependent manner.
  findings: []
- id: PMID:15657060
  title: c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic
    response to DNA damage.
  findings:
  - statement: c-Abl directly binds caspase-9
  - statement: Phosphorylates caspase-9 at Tyr-153 in DNA damage response
  - statement: Y153F mutant attenuates DNA damage-induced apoptosis
- id: PMID:16189514
  title: Towards a proteome-scale map of the human protein-protein interaction 
    network.
  findings: []
- id: PMID:16352606
  title: Caspase-7 is directly activated by the approximately 700-kDa apoptosome
    complex and is released as a stable XIAP-caspase-7 approximately 200-kDa 
    complex.
  findings:
  - statement: Apoptosome directly cleaves/activates procaspase-7
- id: PMID:16537496
  title: The dependence receptor DCC requires lipid raft localization for cell 
    death signaling.
  findings: []
- id: PMID:16916640
  title: 'Engineered hybrid dimers: tracking the activation pathway of caspase-7.'
  findings:
  - statement: Demonstrates caspase-9 activation of caspase-7
- id: PMID:16920334
  title: Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell 
    death.
  findings: []
- id: PMID:16936772
  title: Integrin-linked kinase interacts with caspase-9 and -8 in an 
    adhesion-dependent manner for promoting radiation-induced apoptosis in human
    leukemia cells.
  findings: []
- id: PMID:17167422
  title: Hsp70 regulates erythropoiesis by preventing caspase-3-mediated 
    cleavage of GATA-1.
  findings: []
- id: PMID:18022362
  title: IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB 
    activation, and TNFalpha-dependent apoptosis.
  findings: []
- id: PMID:18309324
  title: 'No death without life: vital functions of apoptotic effectors.'
  findings:
  - statement: Caspases have non-apoptotic functions including platelet 
      formation
- id: PMID:18723680
  title: Executioner caspase-3 and caspase-7 are functionally distinct 
    proteases.
  findings: []
- id: PMID:19153467
  title: The structure of the BIR3 domain of cIAP1 in complex with the 
    N-terminal peptides of SMAC and caspase-9.
  findings: []
- id: PMID:19255499
  title: HIP1R interacts with a member of Bcl-2 family, BCL2L10, and induces 
    BAK-dependent cell death.
  findings: []
- id: PMID:19494828
  title: The Apaf-1*procaspase-9 apoptosome complex functions as a 
    proteolytic-based molecular timer.
  findings: []
- id: PMID:19721007
  title: Netrin-1 up-regulation in inflammatory bowel diseases is required for 
    colorectal cancer progression.
  findings: []
- id: PMID:19740745
  title: A truncated form of p23 down-regulates telomerase activity via 
    disruption of Hsp90 function.
  findings: []
- id: PMID:20462491
  title: Structure of an apoptosome-procaspase-9 CARD complex.
  findings: []
- id: PMID:21827945
  title: 'The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3.'
  findings:
  - statement: Structural evidence for caspase-9 in apoptosome
- id: PMID:21980415
  title: Identification of a conserved anti-apoptotic protein that modulates the
    mitochondrial apoptosis pathway.
  findings: []
- id: PMID:23516580
  title: The E. coli effector protein NleF is a caspase inhibitor.
  findings: []
- id: PMID:25241761
  title: Using an in situ proximity ligation assay to systematically profile 
    endogenous protein-protein interactions in a pathway network.
  findings: []
- id: PMID:25416956
  title: A proteome-scale map of the human interactome network.
  findings: []
- id: PMID:25502805
  title: A massively parallel pipeline to clone DNA variants and examine 
    molecular phenotypes of human disease mutations.
  findings: []
- id: PMID:25519916
  title: The EHEC-host interactome reveals novel targets for the translocated 
    intimin receptor.
  findings: []
- id: PMID:27107012
  title: Pooled-matrix protein interaction screens using Barcode Fusion 
    Genetics.
  findings: []
- id: PMID:27889207
  title: Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic 
    Activity by Two Distinct Mechanisms.
  findings: []
- id: PMID:29997244
  title: 'LuTHy: a double-readout bioluminescence-based two-hybrid technology for
    quantitative mapping of protein-protein interactions in mammalian cells.'
  findings: []
- id: PMID:31467278
  title: Maximizing binary interactome mapping with a minimal number of assays.
  findings: []
- id: PMID:31515488
  title: Extensive disruption of protein interactions by genetic variants across
    the allele frequency spectrum in human populations.
  findings: []
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
- id: PMID:35446120
  title: Calmodulin Binding Activates Chromobacterium CopC Effector to 
    ADP-Riboxanate Host Apoptotic Caspases.
  findings: []
- id: PMID:8663294
  title: ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by 
    the cytotoxic T cell protease granzyme B.
  findings:
  - statement: Original characterization of caspase-9 (ICE-LAP6)
  - statement: Overexpression induces apoptosis
- id: PMID:9390557
  title: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex 
    initiates an apoptotic protease cascade.
  findings:
  - statement: Landmark paper establishing caspase-9 as initiator caspase
  - statement: CARD-CARD interaction with Apaf-1
  - statement: Activates caspase-3
- id: PMID:9922454
  title: 'Ordering the cytochrome c-initiated caspase cascade: hierarchical activation
    of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.'
  findings: []
- id: Reactome:R-HSA-114252
  title: Cleavage of Procaspase-3 by the apoptosome
  findings: []
- id: Reactome:R-HSA-114256
  title: CYCS:APAF1 binds procaspase-9
  findings: []
- id: Reactome:R-HSA-114259
  title: Cleavage of Procaspase‑9 to caspase‑9
  findings: []
- id: Reactome:R-HSA-114261
  title: Cleavage of Procaspase-7 by the apoptosome
  findings: []
- id: Reactome:R-HSA-198621
  title: AKT phosphorylates caspase-9
  findings: []
- id: Reactome:R-HSA-2399985
  title: AKT1 E17K mutant phosphorylates caspase-9
  findings: []
- id: Reactome:R-HSA-373700
  title: Caspase-9 binds DCC:DIP13alpha complex
  findings: []
- id: Reactome:R-HSA-418845
  title: Activation of caspase-3
  findings: []
- id: Reactome:R-HSA-6804596
  title: APAF1:CYCS binds APIP
  findings: []
- id: Reactome:R-HSA-6805426
  title: CARD8 binds CASP9(1-416)
  findings: []
- id: Reactome:R-HSA-9627056
  title: Procaspase 9 forms dimer
  findings: []
- id: Reactome:R-HSA-9627078
  title: XIAP binds CASP9
  findings: []
- id: Reactome:R-HSA-9627089
  title: CASP9 is phosphorylated at T412
  findings: []
- id: file:human/CASP9/CASP9-deep-research-perplexity.md
  title: Deep research report on CASP9
  findings: []
core_functions:
- description: Initiator caspase of the intrinsic (mitochondrial) apoptotic 
    pathway. Upon mitochondrial outer membrane permeabilization (MOMP) and 
    cytochrome c release, caspase-9 (isoform 1) is recruited to the Apaf-1 
    apoptosome via CARD-CARD interactions, where it is activated and 
    cleaves/activates effector caspases-3 and -7 to execute apoptosis.
  molecular_function:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  directly_involved_in:
  - id: GO:0097193
    label: intrinsic apoptotic signaling pathway
  locations:
  - id: GO:0043293
    label: apoptosome
- description: Cysteine-type endopeptidase with strict requirement for Asp at P1
    position and preference for LEHD sequence. Cleaves procaspase-3 and 
    procaspase-7 at their intersubunit linkers to generate active executioner 
    caspases.
  molecular_function:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  substrates:
  - id: UniProtKB:P42574
    label: CASP3
  - id: UniProtKB:P55210
    label: CASP7
- description: 'DNA damage response effector: c-Abl kinase phosphorylates caspase-9
    at Tyr-153 in response to genotoxic stress, promoting caspase-9 autoprocessing
    and apoptosis.'
  molecular_function:
    id: GO:0004197
    label: cysteine-type endopeptidase activity
  directly_involved_in:
  - id: GO:0008630
    label: intrinsic apoptotic signaling pathway in response to DNA damage
- description: 'CRITICAL ISOFORM BIOLOGY: Alternative splicing produces antagonistic
    isoforms. Isoform 1 (Caspase-9L/9a/Alpha) is pro-apoptotic with full catalytic
    activity. Isoform 2 (Caspase-9S/9b/Beta) lacks the catalytic domain and acts as
    a DOMINANT-NEGATIVE INHIBITOR by competing for Apaf-1 binding. The 9L/9S ratio
    determines cellular apoptotic sensitivity.'
  molecular_function:
    id: GO:0030234
    label: enzyme regulator activity
  supported_by:
  - reference_id: PMID:10070954
    supporting_text: Identification of an endogenous dominant-negative short 
      isoform of caspase-9 that can regulate apoptosis
proposed_new_terms: []
suggested_questions:
- question: How do cells regulate the ratio of Caspase-9L to Caspase-9S 
    isoforms, and what splicing factors are involved in this decision?
- question: What is the precise molecular mechanism by which Caspase-9S inhibits
    apoptosis - does it simply sequester Apaf-1 or does it have additional 
    inhibitory mechanisms?
- question: What are the non-apoptotic functions of caspase-9 in autophagy, 
    synaptic plasticity, and vascular function, and how are these regulated 
    independently of apoptosis?
suggested_experiments:
- description: 'Isoform-specific proteomics: Develop isoform-specific antibodies or
    mass spectrometry methods to quantify 9L/9S ratios across tissues and disease
    states.'
- description: 'Structural studies of Caspase-9S in the apoptosome: Determine how
    the truncated isoform interacts with Apaf-1 and whether it truly occupies the
    same binding site as 9L.'
- description: 'Conditional isoform knockout: Generate mice with isoform-specific
    knockouts to determine the specific physiological roles of each isoform.'
alternative_products:
- name: 1 (9L, Alpha)
  id: P55211-1
  description: >-
    The canonical pro-apoptotic isoform (416 AA). Also called Caspase-9L or Caspase-9
    alpha.
    Contains the CARD domain and full catalytic domain. Activated by Apaf-1 in the
    apoptosome
    to initiate the intrinsic apoptotic pathway. Most GO annotations refer to this
    isoform.
- name: 2 (9S, Beta)
  id: P55211-2
  sequence_note: VSP_000818
  description: >-
    The dominant-negative anti-apoptotic isoform (307 AA). Also called Caspase-9S
    or Caspase-9
    beta. Lacks the catalytic domain but retains the CARD domain, allowing it to
    compete with
    Caspase-9L for Apaf-1 binding without triggering apoptosis. The 9L/9S ratio
    determines
    cellular sensitivity to apoptotic stimuli. Overexpressed in some cancers to
    evade apoptosis.
- name: 3 (Gamma)
  id: P55211-3
  sequence_note: VSP_043910, VSP_043911
  description: >-
    A less characterized isoform with alternative splicing affecting the N-terminal
    region.
    Functional studies are limited compared to the 9L and 9S isoforms.
- name: '4'
  id: P55211-4
  sequence_note: VSP_044256
  description: >-
    A less characterized isoform. Functional role not well established in the literature.

CASP9

Gene Description

Existing Annotations Review

Core Functions

Cysteine-type endopeptidase with strict requirement for Asp at P1 position and preference for LEHD sequence. Cleaves procaspase-3 and procaspase-7 at their intersubunit linkers to generate active executioner caspases.

DNA damage response effector: c-Abl kinase phosphorylates caspase-9 at Tyr-153 in response to genotoxic stress, promoting caspase-9 autoprocessing and apoptosis.

References

Suggested Questions for Experts

Suggested Experiments

📚 Additional Documentation

Deep Research Perplexity

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

Target Gene/Protein Identity (from UniProt):

MANDATORY VERIFICATION STEPS:

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

Research Target:

Output

Comprehensive Functional Analysis of Human Caspase-9 (CASP9): Structure, Mechanisms, and Biological Roles

Molecular Structure and Domain Organization of Caspase-9

Structural Architecture and Functional Domains

The Inhibitory Role of the CARD Domain

Activation Mechanisms and the Apoptosome Complex

The Apoptosome Platform and Recruitment

Dual Mechanisms of Caspase-9 Activation

Procaspase-9 Processing and Autocatalytic Cleavage

Substrate Specificity and Catalytic Mechanism

Cleavage Site Recognition and Substrate Selectivity

Differential Substrate Affinity for Holoenzyme Versus Dimerized Forms

The Intrinsic Apoptotic Pathway and Effector Caspase Activation

Procaspase-3 Activation and the Caspase Cascade

Feedback Amplification of Mitochondrial Damage

Requirement for Apoptosome Binding for Sustained Activity

Regulation of Caspase-9 Activity Through Phosphorylation

Inhibitory Phosphorylation Sites

Activating Phosphorylation at Tyrosine-153

Allosteric Inhibition by Akt Kinase

Alternative Splicing and the Caspase-9b Isoform

Regulation of Caspase-9a/9b Splicing Ratios

Localization and Subcellular Compartmentalization

Cytosolic Localization and Apoptosome Assembly

Mitochondrial Translocation During Apoptosis

Non-Apoptotic Functions of Caspase-9

Autophagy Regulation and Mitochondrial Homeostasis

Innate Immune Sensing and Interferon Production

Endothelial Dysfunction and Neurovascular Injury

Synaptic Plasticity and Memory Functions

Regulation of Necroptosis

Developmental Roles and Central Nervous System Formation

Caspase-9 in Embryonic Development and CNS Formation

Non-Apoptotic Neurodevelopmental Functions

Caspase-9 in Cancer Biology and Therapeutic Applications

Caspase-9 Dysregulation in Cancer

Chemotherapy-Induced Apoptosis and Caspase-9 Dependency

Inducible Caspase-9 as a Safety Switch for Cell Therapy

Caspase-9 Inhibition as an Immunotherapy Strategy

Recent Research Developments and Emerging Concepts

Structural and Mechanistic Advances

Comprehensive Substrate Profiling

Caspase-9 Polymorphisms and Disease Association

Conclusion

Citations

Notes

CASP9 (Caspase-9) Notes - ISOFORMS Project

Key Isoform Biology

Isoforms (4 named)

Critical Antagonism: Long vs Short

Mechanism of Antagonism

GOA Annotation Status

Expected Annotation Issues

Biological Significance

Key References

📄 View Raw YAML